ID,Pathogen,Cleaned Name,Original Name,Region,Country,City,Street Address,Postal Code,Contact Phone #,Email Address,Institution Type,URL,Affiliation,Research_Area,Research_Description,Source1,Zika,Inovio Pharmaceuticals,Inovio Pharmaceuticals,America (AMRO),United States,"Plymouth Meeting, PA",660 West Germantown Pike Suite 110,19462,267.440.4200, clinical.trials@inovio.com,Private,http://www.inovio.com,,Vaccine,"Synthetic DNA Vaccine (Platform technology is called ""SynCon""), constructed using multiple Zika antigens",http://ir.inovio.com/news/news-releases/news-releases-details/2016/Inovio-Pharmaceuticals-DNA-Vaccine-for-Zika-Virus-Induces-Robust-Immune-Responses-in-Preclinical-Study/default.aspx2,Zika,GeneOne Life Sciences,GeneOne Life Sciences,Western Pacific (WPRO),South Korea,Seoul,"Suite 1903, 223 Teheran-Ro, Gangnam-Gu",6142,82.2.527.0600,genels@genels.com,Private,http://www.genels.com,,Vaccine,Using DNA-based vaccine - collaborating with Inovio,https://globenewswire.com/news-release/2016/01/22/803925/0/en/GeneOne-Life-Science-and-Inovio-Pharmaceuticals-to-Collaborate-on-Zika-Virus-Vaccine-Development.html3,Zika,Bharat Biotech International Ltd,Bharat Biotech International Ltd,South East Asia (SEARO),India,Hyderabad,"Genome Valley, Turkapally, Shameerpet, Telangana",500078,91.40.2778.4084,exports02@bharatbiotech.com,Private,http://www.bharatbiotech.com,,Vaccine,"Two vaccine candidates - one inactivated, one recombinant",http://www.thehindu.com/sci-tech/health/bharat-biotech-seeks-govt-approval-of-two-zika-vaccine-candidates/article8188330.ece4,Zika,Takeda Pharmaceuticals,Takeda Pharmaceuticals,Western Pacific (WPRO),Japan,Tokyo,"12-10, Nihonbashi 2-chome, Chuo-ku",,81-6-6204-2111,https://www.takeda.com/contact/form/en/,Private,https://www.takeda.com,,Vaccine,"Exploratory phase, looking to cross-apply work from Dengue",http://www.reuters.com/article/us-health-zika-takeda-idUSKCN0VC1095,Zika,Sanofi,Sanofi,Europe (EURO),France,Paris,"54, rue La Boétie ",75008,33 (0)1 53 77 40 00,http://en.sanofi.com/contact/contact.aspx,Private,http://en.sanofi.com,,Vaccine,Live attenuated vaccine,http://hereandnow.wbur.org/2016/04/20/zika-vaccine-development6,Zika,Butantan Institute,Butantan Institute,America (AMRO),Brazil,São Paulo,"Av. Vital Brasil, 1500 – Butantã ",05503-900,(+ 55 11) 2627-9300_,comunicacao@butantan.gov.br,Public,http://www.butantan.gov.br,GloPID-R,Vaccine,"Inactivated vaccine based on ""killed"" Zika virus samples",http://www.nature.com/news/the-race-is-on-to-develop-zika-vaccine-1.196347,Zika,NIH,NIH,America (AMRO),United States,"Bethesda, Maryland",9000 Rockville Pike,20892,301-496-4000, NIHinfo@od.nih.gov,Public,nih.gov,,Funder,Three platforms - (1) DNA-based vaccine repurposed from West Nile (2) Live attenuated vaccine based on Dengue (3) Investigational vaccine based on vesicular stomatitis virus,https://www.niaid.nih.gov/topics/zika/researchapproach/Pages/vaccineResearch.aspx8,Zika,Merck & Co,Merck & Co,America (AMRO),United States,"Kenilworth, NJ",2000 Galloping Hill Road,07033,908-740-4000,,Private,merck.com,,Vaccine,Partnering with NewLink to use flavivirus platforms,http://www.fool.com/investing/general/2016/04/16/the-race-to-cure-the-zika-virus-is-on-and-this-com.aspx9,Zika,NewLink Genetics Corp,NewLink Genetics Corp,America (AMRO),United States,"Ames, IA",2503 South Loop Drive Suite 5100,50010,515-296-5555,info@newlinkgenetics.com,Private,http://www.newlinkgenetics.com,,Vaccine,"Partnering with Merck, looking to repurpose vaccine platforms",http://www.fool.com/investing/general/2016/02/08/can-newlink-genetics-win-the-zika-vaccine-race.aspx10,Zika,Johnson & Johnson,Johnson & Johnson,America (AMRO),United States,"New Brunswick, New Jersey ",One Johnson & Johnson Plaza,08933,(732) 524-0400,https://www.ccc-consumercarecenter.com/universal-contact-us/us-jnj-ucu/www.jnj.com,Private,http://www.jnj.com,,Vaccine,Exploratory phase - looking to use existing technologies,http://blog.ihs.com/the-spread-of-the-zika-threat-and-the-response-of-the-global-pharma-industry-%E2%80%93-parallels-to-ebola-but-important-distinctions11,Zika,GlaxoSmithKline,GlaxoSmithKline,Europe (EURO),United Kingdom,Middlesex,980 Great West Road Brentford,TW8 9GS,44 (0)20 8990 9000,,Private,http://uk.gsk.com,,Vaccine,Exploratory phase - no public disclosure to date,http://economictimes.indiatimes.com/news/international/world-news/gsk-evaluating-possibility-of-using-vaccine-technology-for-zika/articleshow/50723411.cms12,Zika,Sementis Ltd,Sementis Ltd,Western Pacific (WPRO),Australia,"Berwick Melbourne, Victoria","Sing Crescent 9, Centre For Industrial Research",3806,0402 294 797,http://www.sementis.com.au/contact-us,Private,http://www.sementis.com.au,,Vaccine,"Cross-applying platform for chikungunya, in clinical manufacturing process (2-16-16)",http://www.unisa.edu.au/Media-Centre/Releases/UniSA-industry-partnership-seeks-vaccine-for-Zika-virus/#.VzaVmBUrJD013,Zika,Hawaii Biotech,Hawaii Biotech,America (AMRO),United States,"Aiea, HI",99-193 Aiea Heights Dr # 200,96701,(808) 486-5333,info@hibiotech.com,Private,http://www.hibiotech.com/index.html,,Vaccine,"Molecular vaccine, previous work on Dengue and West Nile",http://www.hawaiinewsnow.com/story/31866151/hawaii-biotech-to-work-on-zika-vaccine14,Zika,Replikens Ltd,Replikens Ltd,America (AMRO),United States,"Boston, MA",36 Fenway,02215, (646) 320-5910,info@replikins.com,Private,http://www.replikins.com/index.html,,Vaccine,Synthetic genomic-based peptide vaccine-blocker for Zika virus ,http://www.prnewswire.com/news-releases/zika-gene-replikin-count-at-highest-level-observed-300210265.html15,Zika,Pfizer Inc,Pfizer Inc,America (AMRO),United States,"New York City, NY",235 East 42nd Street,10017,1-212-733-2323,https://www.pfizer.com/contact/email_contact?inquiry=Clinical%20Research,Private,http://www.pfizer.com,,Vaccine,Exploratory phase - looking to use existing technologies,http://www.theguardian.com/world/2016/apr/17/us-zika-outbreaks-likely-world-health-organization16,Zika,GeoVax Labs Inc.,GeoVax Labs Inc.,America (AMRO),United States,"Smyrna, GA","1900 Lake Park Drive, Suite 380",30080,678-384-7220,info@geovax.com,Private,http://geovax.com,,Vaccine,"Modified Vaccinia Virus Ankara –Virus-Like Particle (MVA-VLP) platform, previously used for Ebola and HIV",http://www.geovax.com/news-events/entry/2016/04/18/geovax-provides-update-on-zika-vaccine-program.html17,Zika,University of Georgia,University of Georgia,America (AMRO),United States,"Athens, GA",The University of Georgia,30602,706-542-5969,dclee@uga.edu,Academic,http://www.uga.edu,,Vaccine,Collaborating with GeoVax - UGA's Center for Vaccines and Immunology,http://www.geovax.com/news-events/entry/2016/04/18/geovax-provides-update-on-zika-vaccine-program.html18,Zika,UNICEF,UNICEF,America (AMRO),United States,"New York, NY","UNICEF House, 3 United Nations Plaza",10017,1-212-326-7000,http://www.unicef.org/about/contact_contactusform.php,Public,http://www.unicef.org,,Funder,Call for money to fund vaccine R&D - working with Google,https://www.unicefusa.org/stories/unicef-teams-google-fight-zika/3003519,Zika,University of South Austrailia,University of South Austrailia,Western Pacific (WPRO),Australia,Adelaide SA,101 Currie St,50001,61 8 8302 6611,"Kelly.stone@unisa.edu.au, john.hayball@unisa.edu.au",Academic,https://www.unisa.edu.au,,Vaccine,Working with Sementis,http://www.unisa.edu.au/Media-Centre/Releases/UniSA-industry-partnership-seeks-vaccine-for-Zika-virus/#.VzaVmBUrJD020,Zika,Google,Google,America (AMRO),United States,"Mountain View, CA ",1600 Amphitheatre Parkway,94043,1-650-253-0000,https://www.google.com/contact/,Private,https://www.google.com/about/company/,,Funder,Donated $1 million to UNICEF to fund Zika R&D,https://www.unicefusa.org/stories/unicef-teams-google-fight-zika/3003521,Zika,University of Texas Medical Branch,University of Texas Medical Branch,America (AMRO),United States,"Galveston, TX",301 University Blvd,77555,(409) 772-1011, public.affairs@utmb.edu,Academic,http://www.utmb.edu,Global Zika Task Force,Laboraty Methods,Providing reagents to test Geovax's work,http://www.geovax.com/news-events/entry/2016/04/18/geovax-provides-update-on-zika-vaccine-program.html22,Zika,University of Miami Center for AIDS Research,University of Miami Center for AIDS Research,America (AMRO),United States,"Miami, FL",1800 NW 10th Ave,33136,(305) 243-3838,dcfar@med.miami.edu,Academic,http://cfar.med.miami.edu,Global Zika Task Force,Epidemiology,Hosted conference where GeoVax presented initial data,http://www.geovax.com/news-events/entry/2016/05/02/geovax-presents-at-zika-virus-scientific-conference.html23,Zika,Emory School of Medicine,Emory School of Medicine,America (AMRO),United States,"Atlanta, GA",1648 Pierce Dr NE,30307,(404) 727-5640,alevey@emory.edu,Academic,http://med.emory.edu/index.html,Global Zika Task Force,Epidemiology,Various academic researchers specializing in infectious diseases associated with Aedes Aegypti,http://news.emory.edu/stories/tip_sheets/tipsheet_zika_experts/24,Zika,Washington University School of Medicine,Washington University School of Medicine,America (AMRO),United States,"St. Louis, MO",660 S Euclid Ave,63110, (314) 362-5000,mpa@wusm.wustl.edu,Academic,https://medicine.wustl.edu,Global Zika Task Force,Vaccine,Developed a mouse model for testing Zika vaccines,https://medicine.wustl.edu/news/new-mouse-model-aid-testing-zika-vaccine-therapeutics/25,Zika,Colorado State University,Colorado State University,America (AMRO),United States," Fort Collins, CO",Colorado State University,80523,(970) 491-7194, presofc@lamar.colostate.edu,Academic,http://www.colostate.edu,Global Zika Task Force,Epidemiology,Working with the CDC to understand transmission,http://www.coloradoan.com/story/news/2016/02/12/fort-collins-cdc-branch-ground-zero-zika-virus-research/80316454/26,Zika,University of Wisconsin School of Veterinary Medicine,University of Wisconsin School of Veterinary Medicine,America (AMRO),United States,"Madison, WI",2015 Linden Dr,53706,(608) 263-7600,http://www.vetmed.wisc.edu/about-the-school/contact-us/,Academic,http://www.vetmed.wisc.edu,Global Zika Task Force,Vaccine,Developed a mouse model for testing Zika vaccines,http://www.vetmed.wisc.edu/new-model-for-zika-research/27,Zika,Yale School of Public Health,Yale School of Public Health,America (AMRO),United States,"New Haven, CT","60 College Street, P.O. Box 208034",06520-8034,(203) 785-4689,https://publichealth.yale.edu/about/contact/,Academic,https://publichealth.yale.edu,Global Zika Task Force,Epidemiology,Focusing on epidemiology of Zika,https://publichealth.yale.edu/emd/28,Zika,National Institute of Allergies and Infectious Diseases (NIAID),National Institute of Allergies and Infectious Diseases (NIAID),America (AMRO),United States,"Bethesda, MD","5601 Fishers Lane, MSC 9806",20892-9806,866-284-4107,ocpostoffice@niaid.nih.gov,Public,https://www.niaid.nih.gov/Pages/default.aspx,Global Zika Task Force,All,Three platforms - (1) DNA-based vaccine repurposed from West Nile (2) Live attenuated vaccine based on Dengue (3) Investigational vaccine based on vesicular stomatitis virus,https://www.niaid.nih.gov/topics/zika/researchapproach/Pages/vaccineResearch.aspx29,Zika,UCSF School of Medicine,UCSF School of Medicine,America (AMRO),United States,"San Francisco, CA",505 Parnassus Ave, 94143,415-514-8884,ctsi@ucsf.edu,Academic,https://medschool.ucsf.edu,Global Zika Task Force,Laboraty Methods,DNA sequencing of mosquito host and Zika virus,http://sanfrancisco.cbslocal.com/2016/05/03/bay-area-scientists-join-forces-to-help-contain-zika-virus/30,Zika,United States Army Medical Research Institute of Infectious Disease (USARMIID),United States Army Medical Research Institute of Infectious Disease (USARMIID),America (AMRO),United States,"Frederick, MD","Attn: MCMR-UIZ-R, 1425 Porter Street",21702-5011,(301) 619-2285,teresa.l.vanderlinden.civ@mail.mil,Public,http://www.usamriid.army.mil,"Global Zika Task Force, ISARIC",Laboraty Methods,Partnering with other organizations to develop diagnostic tests for Zika,http://www.clinicalrm.com/may-4-2016-press-release-clinicalrm-supports-u-s-zika-emergency-response/31,Zika,Johns Hopkins Bloomberg School of Public Health,Johns Hopkins Bloomberg School of Public Health,America (AMRO),United States,"Baltimore, MD",615 N. Wolfe Street,21205,410-955-3543,http://www.jhsph.edu/about/contact-us/,Academic,http://www.jhsph.edu,Global Zika Task Force,All,Applying work from Dengue to Zika,http://www.nature.com/news/dengue-vaccine-aces-trailblazing-trial-1.1957632,Zika,University of Antioquia,University of Antioquia,America (AMRO),Colombia,"Medellín, Antioquia",Calle 67 Número 53 - 108,1226,57 4 2198332,investigacioninter@udea.edu.co,Academic,http://www.udea.edu.co/wps/portal/udea/web/home,Global Zika Task Force,Vector Control,Using immunized mosquitos against Aedes Aegypti,http://english.cntv.cn/2016/02/17/VIDEugZD9xzawdXZRHiguaYL160217.shtml33,Zika,Institut Pasteur de Dakar,Institut Pasteur de Dakar,Africa (AFRO),Senegal,B.P. 220 - DAKAR,"36, Avenue Pasteur",,221 33 839 92 00,pasteurdakar@pasteur.sn ,Nonprofit ,http://www.pasteur.sn,Global Zika Task Force,Laboraty Methods,Working on diagnostic tests for Zika ,http://www.pasteur.fr/en/institut-pasteur/press/fact-sheets/zika34,Zika,Makerere University Uganda Virus Research Institute,Makerere University Uganda Virus Research Institute,Africa (AFRO),Uganda,Entebbe,"P.O.BOX 49, Nakiwogo Road, Plot 51-59",,2.56414E+11,alison.tom@infocom.co.ug,Academic,http://www.muii.org.ug,"Global Zika Task Force, EDCT",Vector Control,"Discovered the virus, working on health system strategies to control virus in the present, early R&D as a part of the global task force",http://foreignpolicy.com/2016/02/10/uganda-discovered-the-zika-virus-and-the-solution-for-it/35,Zika,Institut Pasteur,Institut Pasteur,Europe (EURO),France,"Paris, France", 25-28 Rue du Dr Roux,75015,33 1 45 68 80 00,,Nonprofit ,http://www.pasteur.fr/en,Global Zika Task Force,All,"Working to confirm link to microcephaly, early vaccine R&D",http://www.pasteur.fr/en/institut-pasteur/press/press-documents/zika-confirmation-causal-link-between-zika-virus-and-guillain-barre-syndrome36,Zika,Institut de Recherche pour le Développement (IRD),Institut de Recherche pour le Développement (IRD),Europe (EURO),France,Marseille cedex 02,"Le Sextant, 44, bd de Dunkerque, CS 90009",13572 ,33 (0)4 91 99 92 00,https://en.ird.fr/infos-pratiques/contact-us,Public,https://en.ird.fr,Global Zika Task Force,Vector Control,"Working on insecticides, insect sterility, and co-vaccination strategies",https://www.ird.fr/toute-l-actualite/actualites/communiques-et-dossiers-de-presse/cp-2016/les-recherches-de-l-ird-sur-le-virus-zika-prevention-et-traitement-de-l-infection37,Zika,University of Glasglow Centre of Virus Research,University of Glasglow Centre of Virus Research,Europe (EURO),United Kingdom,"Bearsden, Glasgow, Lanarkshire",464 Bearsden Rd,G61 1QH,44 (0)141 330 4017,Massimo.Palmarini@glasgow.ac.uk,Academic,http://www.gla.ac.uk/researchinstitutes/iii/cvr/,Global Zika Task Force,Epidemiology,"Working on understanding transmission, immune response, and epidemiology",http://www.gla.ac.uk/research/infocus/themes/zikavirus/38,Zika,National Institute of Infectious Diseases,National Institute of Infectious Diseases,Europe (EURO),Italy,Rome,Via Portuense 292,00149,,giuseppe.ippolito@inmi.it,Public,http://www.inmi.it,Global Zika Task Force,Epidemiology,Part of Global Virus Network; general pre-clinical R&D,http://www.inmi.it/file/comunicati_stampa/2016/Zika%20Task%20Force%20Press%20Release.pdf39,Zika,Universitat Autonoma de Barcelone Centre de Recerca en Sanitat Animal,Universitat Autonoma de Barcelone Centre de Recerca en Sanitat Animal,Europe (EURO),Spain,Barcelona,"Campus de la UAB, edifici CReSA, 08193 Bellaterra (Cerdanyola del Vallès)",,34 934 67 40 40,http://www.cresa.es/cresa3/default.asp?mod=strmenu61,Academic,http://www.cresa.es/cresa3/default.asp,Global Zika Task Force,Vector Control,Researchers working on virus vectors are part of the Global Virus Network,http://www.cresa.es/cresa3/default.asp?mod=strmenu01&anio=2016&sub=noticia35240,Zika,Curtin University,Curtin University,Western Pacific (WPRO),Australia,"Bentley, Perth, WA ",Kent St,6102,61 8 9266 9266,https://askcurtin.custhelp.com/app/ask,Academic,http://www.curtin.edu.au,Global Zika Task Force,Epidemiology,Researching link between Zika and GBS,http://www.cidrap.umn.edu/news-perspective/2016/03/study-shows-strong-link-between-zika-infection-gbs41,Zika,University of Malaya,University of Malaya,Western Pacific (WPRO),Malaysia,Kuala Lumpur,"Institute of Research Management and Monitoring (IPPP), Research Management & Innovation Complex",50603,603-7967 4525,ippp@um.edu.my,Academic,https://www.um.edu.my,Global Zika Task Force,Vector Control,"Part of Global Virus Network; mechanical, chemical (insecticide) and biological (vaccine) R&D",http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf42,Zika,Novavax,Novavax,America (AMRO),United States,"Gaithersburg, MD ",20 Firstfield Road,20878,(240) 268-2000,busdev@novavax.com,Private,novavax.com,,Vaccine,Exploratory R&D,http://www.fiercepharma.com/r-d/novavax-explores-zika-vaccine-r-d-effort-as-virus-continues-to-spread43,Zika,UK Medical Research Council,UK Medical Research Council,Europe (EURO),Europe,"London, UK","Medical Research Council, 14th floor, One Kemble Street",WC2B 4AN,020 7395 2345,corporate@headoffice.mrc.ac.uk,Public,http://www.mrc.ac.uk,"Zika Rapid Response Iniative, EDCTP",Funder,Funding vaccine R&D,https://www.mrc.ac.uk/news/browse/research-funders-join-forces-to-tackle-zika-virus-with-3-2m/44,Zika,Wellcome Trust,Wellcome Trust,Europe (EURO),United Kingdom,London ,"Gibbs Building, 215 Euston Road",NW1 2BE,44 (0)20 7611 8888,contact@wellcome.ac.uk,Public,http://www.wellcome.ac.uk,"Zika Rapid Response Iniative, GloPID- R",Funder,"Funding broad Zika research on microcephaly, transmission, and ethics of pregnancy clinical trials",http://www.glopid-r.org/wp-content/uploads/2016/05/findings-of-zika-research-working-groups-on-vaccines-aetiology-and-diagnostics.pdf45,Zika,Newton Fund,Newton Fund,Europe (EURO),United Kingdom,,,,,enquiries@newtonfund.ac.uk,Public,http://www.newtonfund.ac.uk,Zika Rapid Response Iniative,Funder,Joint R&D funding with MRC and Wellcome,http://www.glopid-r.org/wp-content/uploads/2016/05/findings-of-zika-research-working-groups-on-vaccines-aetiology-and-diagnostics.pdf46,Zika,São Paulo Research Foundation FAPESP,São Paulo Research Foundation FAPESP,America (AMRO),Brazil,São Paulo - SP,"R. Pio XI, 1500 - Alto da Lapa",05468-140,55 11 3838-4000,http://www.fapesp.br/en/contactus/,Public,http://www.fapesp.br/en/,"Zika Rapid Response Iniative, GloPID- R",Funder,Collaborating with Butantan to improve anti-ZIKV antibodies,http://www.glopid-r.org/wp-content/uploads/2016/05/findings-of-zika-research-working-groups-on-vaccines-aetiology-and-diagnostics.pdf47,Zika,Global Challenges Research Fund,Global Challenges Research Fund,Europe (EURO),United Kingdom,,,,44 1793 414665,gcrf@bbsrc.ac.uk ,Public,,Zika Rapid Response Iniative,Funder,Rapid response funding (1 million) for diagnostics and therapeutics,https://www.mrc.ac.uk/news/browse/rapid-response-launched-to-fast-track-zika-research/48,Zika,European Commission,European Commission,Europe (EURO),Europe,,Variety of local offices: http://ec.europa.eu/contact/local_offices_en.htm,,00800 67 89 10 11,http://europa.eu/contact/write-to-us/index_en.htm,Public,http://ec.europa.eu/index_en.htm,GloPID-R,Funder,Released 10 million in R&D funds,http://ec.europa.eu/research/health/index.cfm?pg=area&areaname=zika49,Zika,Access Bio Inc.,Access Bio Inc.,America (AMRO),United States,"Somerset, NJ",65 Clyde Rd. Suite A,08873,,http://www.accessbio.net,Private,http://www.accessbio.net,,Laboraty Methods,Developing point-of-care diagnostics,http://www.ghif.com/uncategorized/ghif-invests-in-access-bio/50,Zika,University of Maryland,University of Maryland,America (AMRO),United States,"College Park, MD",,20742,301.405.1000, emailum@umd.edu,Academic,http://www.umd.edu,,Vaccine,Formed research consortium for vaccine development,http://www.baltimoresun.com/health/bs-hs-zika-task-force-20160215-story.html51,Zika,Atheric Pharmaceutical LLC,Atheric Pharmaceutical LLC,America (AMRO),United States,"Scottsville, VA",10029 Hatton Ferry Rd,24590,(434) 286-3151,Robert.Malone@Atheric.com,Private,http://www.atheric.com,,Therapeutics,Using re-purposed drugs (e.g. anti-malaria medication) for Zika and other flaviviruses ,http://www.atheric.com/52,Zika,The Immunobiological Technology Institute (Bio-Manguinhos),The Immunobiological Technology Institute (Bio-Manguinhos),America (AMRO),Brazil,"Manguinhos, Rio de Janeiro - RJ",Avenida Brasil 4.365,21.040-900,(21) 3882-9393,faleconosco@bio.fiocruz.br,Public,http://portal.fiocruz.br/en/content/immunobiological-technology-institute-biomanguinhos,,Laboraty Methods,"Developed quick-test kits for detection, partnering with other Brazilian players for vaccine R&D",http://agenciabrasil.ebc.com.br/en/geral/noticia/2016-02/government-probes-deep-zika-linked-death53,Zika,Themis Bioscience,Themis Bioscience,Europe (EURO),Austria,Wein, Muthgasse 11,1190,43 1 236 7151,office@themisbio.com,Private,http://www.themisbio.com/#/,,Vector Control,"Collaborating with Institut Pasteur on measles vectors for Zika, previous work on chikungunya",http://www.greffex.com/wp-content/uploads/2016/05/JRP-ZIIKA-Write-up-F2.pdf54,Zika,Valneva,Valneva,Europe (EURO),France,Lyon,"World Trade Center Lyon, Tour Oxygène, 10-12 boulevard Marius Vivier Merle",690073,33 4 78 76 61 01 ,http://www.valneva.com/en/company/contact,Private,http://www.valneva.com/en/,,Vaccine,Proof-of-concept work with its IXIARO platform for Zika (originally designed for Japanese encephalitis),"""Valneva Reports Strong Q1 Revenue Growth and Positive EBITDA;Reaffirms Financial Guidance and Pipeline Outlook for 2016"""55,Zika,US Center for Disease Control and Prevention CDC (USA),US Centers for Disease Control and Prevention (CDC),America (AMRO),United States,"Atlanta, GA",1600 Clifton Road,30333,800-CDC-INFO,https://wwwn.cdc.gov/dcs/ContactUs/Form,Public,http://www.cdc.gov,,All,Working with NIAID and the NIH,https://www.niaid.nih.gov/topics/zika/researchapproach/Pages/vaccineResearch.aspx56,Zika,US Center for Disease Control and Prevention CDC (USA),US Center for Disease Control and Prevention CDC (USA),America (AMRO),United States,"Atlanta, GA",1600 Clifton Road,30333,800-CDC-INFO,https://wwwn.cdc.gov/dcs/ContactUs/Form,Public,http://www.cdc.gov,,Laboraty Methods,CDC Zika MAC-ELISA,http://www.cdc.gov/media/releases/2016/s0226-laboratory-test-for-zika-virus.html57,Zika,US Center for Disease Control and Prevention CDC (USA),US Center for Disease Control and Prevention CDC (USA),America (AMRO),United States,"Atlanta, GA",1600 Clifton Road,30333,800-CDC-INFO,https://wwwn.cdc.gov/dcs/ContactUs/Form,Public,http://www.cdc.gov,,Laboraty Methods,CDC Trioplex Real-time RT-PCR Assay (Trioplex rRT-PCR),http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm#zika58,Zika,Leomics Inc.,Leomics Inc.,America (AMRO),United States,,,,[201] 248-8313,jorgeleon@leomics.com,Private,http://www.leomics.com,,Laboraty Methods,Evaluating a new diagnostic test for Zika,https://sitefinder.tghn.org/studies/evaluation-of-a-new-diagnostic-test-for-zika-virus-infection/59,Zika,Oswaldo Cruz Foundation(Fiocruz),Oswaldo Cruz Foundation(Fiocruz),America (AMRO),Brazil,Rio de Janeiro,"Av. Brazil, 4365 - Manguinho",21040-900 ,(0xx21)2598-4242,,Public,http://portal.fiocruz.br/en/content/home-inglês,GloPID-R,Funder,Repurposing research from flavivirus laboratory,http://www.who.int/bulletin/volumes/94/3/16-030316/en/60,Zika,The Jenner Institutue (Oxford University),The Jenner Institutue (Oxford University),Europe (EURO),United Kingdom,Oxford, Roosevelt Dr,OX3 7DQ,44 1865 617611,adrian.hill@ndm.ox.ac.uk,Academic,http://www.jenner.ac.uk/home,Zika Virus Vaccine Program,Vaccine,Developing vaccine based on adenoviral vector,http://www.jenner.ac.uk/zika-virus-vaccine-programme61,Zika,Benemérita Universidad Autónoma de Puebla,Benemérita Universidad Autónoma de Puebla,America (AMRO),Mexico,"Heroica Puebla de Zaragoza, PUE","Calle 4 Sur 104, Centro Historico", 72000 ,52 222 229 5500,juan.morales@correo.buap.mx,Academic,http://www.buap.mx,Zika Virus Vaccine Program,Laboraty Methods,PCR based diagnosis of Zika; collaboration with Oxford to test immunogenicity,http://www.buap.mx/portal_pprd/wb/comunic/el_centro_de_deteccion_biomolecular_de_la_buap_est62,Zika,Universidad Michoacana San Nicolás de Hidalgo,Universidad Michoacana San Nicolás de Hidalgo,America (AMRO),Mexico,"Morelia, Michoacana","Gral. Francisco J. Mugica S/N, Ciudad Universitaria",58030,52 443 322 3500,,Academic,http://www.umich.mx/index.html,Zika Virus Vaccine Program,Vaccine,Working with Oxford,http://www.ndm.ox.ac.uk/mexico/background63,Zika,Instituto Mexicano del Seguro Social,Instituto Mexicano del Seguro Social,America (AMRO),Mexico,"Ciudad de México, D.F.","Calle Reforma 476, Cuauhtémoc, Juárez",06600,52 55 5527 3200,http://201.149.45.42/atencionimss/atencion.html,Public,http://www.imss.gob.mx,Zika Virus Vaccine Program,Vaccine,Working with Oxford,http://www.ndm.ox.ac.uk/mexico/background64,Zika,Centro Médico Nacional Siglo XXI,Centro Médico Nacional Siglo XXI,America (AMRO),Mexico,"Ciudad de México, D.F.","Av. Cuauhtémoc 300, Cuauhtemoc, Doctores",06720,52 55 5627 6900,http://201.149.45.42/atencionimss/atencion.html,Public,http://imss.gob.mx/directorio/instalacion/hped-cmn-siglo-xxi,Zika Virus Vaccine Program,Vaccine,Working with Oxford,http://www.ndm.ox.ac.uk/mexico/background65,Zika,Immunovaccine,Immunovaccine,America (AMRO),Canada,"Halifax, NS",1819 Granville St,B3J 3R1,1 902-492-1819, info@imvaccine.com ,Private,https://www.imvaccine.com,,Vaccine,Using single-dose vaccine platform (DepoVax) for Zika R&D,https://www.imvaccine.com/releases.php?releases_id=38166,Zika,Leidos,Leidos,America (AMRO),United States,"Reston, VA ",11951 Freedom Drive ,20190 ,(571) 526-6000,https://www.leidos.com/contact,Private,https://www.leidos.com,,Vaccine,Working with Immunovaccine,http://investors.leidos.com/phoenix.zhtml?c=193857&p=irol-newsArticle&ID=215519267,Zika,Protein Sciences,Protein Sciences,America (AMRO),United States,"Meriden, CT ",1000 Research Parkway,06450,(800) 488-7099,http://www.proteinsciences.com/contact.htm,Private,http://www.proteinsciences.com,,Vaccine,Developing E-protein recombinants for Zika vaccine,http://www.proteinsciences.com/VAC.htm#VAC568,Zika,Sinergium,Sinergium,America (AMRO),Argentina,"Garin, Buenos Aires",Ruta Panamericana Km 38.7,P1619IEA,54 11 3220-7300,http://www.sinergiumbiotech.com/en/contacto/,Private,http://www.sinergiumbiotech.com/en/,,Vaccine,Collaborating with Protein Sciences,http://www.prnewswire.com/news-releases/protein-sciences-corporation-sinergium-biotech-and-mundo-sano-announce-zika-vaccine-partnership-300253766.html69,Zika,Mundo Sano,Mundo Sano,America (AMRO),Argentina, Ciudad de Buenos Aires,Paraguay 1535,C1061ABC,(+54 11) 4872-1333,mundosano@mundosano.org,Nonprofit ,http://www.mundosano.org/en/,,Vaccine,Collaborating with Protein Sciences,http://www.prnewswire.com/news-releases/protein-sciences-corporation-sinergium-biotech-and-mundo-sano-announce-zika-vaccine-partnership-300253766.html70,Zika,Oxis International Inc.,Oxis International Inc.,America (AMRO),United States,"Tampa, FL","100 South Ashley Drive, Suite 600",33602,,http://www.oxis.com/contact,Private,http://www.oxis.com,,Therapeutics,Small molecule inhibition of non-structural ZIKV proteins,http://www.prnewswire.com/news-releases/oxis-continues-push-for-zika-cure-following-new-confirmed-case-in-south-korea-300241799.html71,Zika,University of Pittsburgh,University of Pittsburgh,America (AMRO),United States,"Pittsburgh, PA",4200 Fifth Ave,15260, 412-624-4141,,Academic,http://www.pitt.edu,,Vaccine,"Formed international R&D partnership, Cura Zika",http://www.publichealth.pitt.edu/curazika72,Zika,Genekam Biotechnology AG,Genekam Biotechnology AG,Europe (EURO),Germany,Duissern,Duissern Str. 65a,47058,"49 203 / 555858-31,-32,-33 ",anfrage@genekam.de,Private,http://genekam.de/products.php,,Laboraty Methods,DNA test for Zika virus detection,http://genekam.de/press/Press-release-zika-virus.php73,Zika,Fast-track Diagnostics,Fast-track Diagnostics,Europe (EURO),Malta,Sliema,"Seaview No. 2, Qui-Si-Sana Seafront",3110,356-2765-4302, Info@fast-trackdiagnostics.com,Private,http://www.fast-trackdiagnostics.com,,Laboraty Methods,Nucleic acid based kit for Zika detection,http://www.fast-trackdiagnostics.com/news-events/new-ftd-zikadenguechik-assay-now-available/74,Zika,Altona Diagnostics,Altona Diagnostics,Europe (EURO),Germany,Hamburg,Mörken strasse. 12,22767,49 40 548 06 76 - 0,info@altona-diagnostics.com,Private,http://www.altona-diagnostics.com/history.html,,Laboraty Methods,RT-PCR kit for Zika detection,http://www.altona-diagnostics.com/realstar-zika-virus-rt-pcr-kit-354.html75,Zika,GenArraytion,GenArraytion,America (AMRO),United States,"Rockville, MD ",9610 Medical Center Dr #230,20850,(240) 453-6312,pschaudies@genarraytion.com,Private,http://www.genarraytion.com,,Laboraty Methods,PCR-based test for Zika detection,http://www.businesswire.com/news/home/20160129005841/en/GenArraytion-Introduces-Commercially-Test-Identify-Zika-Virus76,Zika,Luminex,Luminex,America (AMRO),United States,"Austin, TX","12212 Technology Blvd, Suite 130 ", 78727,1-512-336-3550,orders@luminexcorp.com,Private,https://www.luminexcorp.com,,Laboraty Methods,Working with USP (Brazil) to validate detection platform,http://www.prnewswire.com/news-releases/luminex-corporation-announces-collaboration-with-university-of-sao-paulo-to-validate-zika-virus-detection-panel-300226525.html77,Zika,Genesig,Genesig,Europe (EURO),United Kingdom,Chandler's Ford,"Primerdesign Ltd, York House, School Lane",SO53 4DG,44 (0)2380 748 830,enquiry@primerdesign.co.uk,Private,http://www.genesig.com/home,,Laboraty Methods,Nucleic acid testing for Zika,http://www.genesig.com/products/974278,Zika,My Biosource,MyBioSource,America (AMRO),United States,"San Diego, CA ",  P.O. Box 153308,92195-3308,1.858.633.0165    ,sales@mybiosource.com,Private,http://www.mybiosource.com,,Laboraty Methods,ELISA-based kit for Zika detection,http://www.mybiosource.com/prods/ELISA-Kit/Human/Zika-Virus-IgG-ZV-IgG/ZV-IgG/datasheet.php?products_id=10900279,Zika,My Biosource,My Biosource,America (AMRO),United States,"San Diego, CA ",  P.O. Box 153308,92195-3308,1.858.633.0165    ,sales@mybiosource.com,Private,http://www.mybiosource.com,,Laboraty Methods,ELISA-based kit for Zika detection,80,Zika,My Biosource,My Biosource,America (AMRO),United States,"San Diego, CA ",  P.O. Box 153308,92195-3308,1.858.633.0165    ,sales@mybiosource.com,Private,http://www.mybiosource.com,,Laboraty Methods,ELISA-based kit for Zika detection,81,Zika,Statens Serum Institute,Statens Serum Institute,Europe (EURO),Denmark,Copenhagen S,5 Artillerivej ,DK-2300,45 3268 3268,serum@ssi.dk,Public,http://www.ssi.dk/english.aspx,EDCTP,Laboraty Methods,Antibody isolation for Zika detection,http://www.ssi.dk/diagnostik/diagnostiskhaandbog/2000-2099/2017.aspx82,Zika,Zika Real time PCR kit,Zika Real time PCR kit,Western Pacific (WPRO),China,Shanghai,"Shanghai Zhijiang Biotechnology Limited Company, 2nd floor, No.15 Building, No.188 Xinjunhuan Road, PuJiang Hi-tech Park",,86-21-34680596,trade@liferiver.com.cn,Public,www.liferiver.com.cn,,Laboraty Methods,PCR kit for Zika virus RNA,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf83,Zika,"Co-Diagnostics, Inc.","Co-Diagnostics, Inc.",America (AMRO),United States,"Bountiful, UT",585 W 500 S # 210,84010,(801) 683-8994,info@codiagnostics.com,Private,http://codiagnostics.com,,Laboraty Methods,Qualitative PCR kit for the detection of Zika virus nucleic acids,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf84,Zika,Fiocruz,Fiocruz,America (AMRO),Brazil,Rio de Janeiro,"Av. Brazil, 4365 - Manguinho",21040-900 ,(0xx21)2598-4242,,Public,http://portal.fiocruz.br/en/content/home-inglês,GloPID-R,Laboraty Methods,"Zika, Dengue and Chikungunya multiplex PCR kit",http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf85,Zika,Experimental Therapeutics Centre (ETC) - Agency for Science Technology Research,Experimental Therapeutics Centre (ETC) - Agency for Science Technology Research,Western Pacific (WPRO),Singapore,Singapore,"1 Fusionopolis Way, #20-10 Connexis North Tower",138632,(65) 6826 6111 , contact@a-star.edu.sg,Public,https://www.a-star.edu.sg/About-A-STAR/Biomedical-Research-Council/Biomedical-Research-Institutes-Consortia.aspx,,Laboraty Methods,Developing a multiplex PCR assay that will be used in hospital laboratories,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf86,Zika,Vela Diagnostics,Vela Diagnostics,Western Pacific (WPRO),Singapore,Singapore,"50 Science Park Road, #05-07 The Kendall",117406,65 6672 6060,http://www.veladx.com/contact/contact-form.html,Private,http://www.veladx.com,,Laboraty Methods,PCR kit – Zika PCR assay to be added to current multiplex PCR kit containing Chikungunya and Dengue,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf87,Zika,Vista NanoBioSensor/Vista Therapeutics,Vista NanoBioSensor/Vista Therapeutics,America (AMRO),United States,"Santa Fe, NM","Vista Therapeutics, Inc., 3900 Paseo del Sol",87507,1-505-474-3143,info@vistananobiosciences.com,Private,http://www.vistatherapeutics.org,,Laboraty Methods,Identification of viral particles using nanotechnology,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf88,Zika,Thermo Fisher,Thermo Fisher,America (AMRO),United States,"South San Francisco, CA ",180 Oyster Point Blvd,94080,(800) 955-6288,csecommerce@lifetech.com,Private,https://www.thermofisher.com/us/en/home.html,,Laboraty Methods,Anti-ZIKV ELISA tests,http://www.businesswire.com/news/home/20160222006521/en/Thermo-Fisher-Scientific-Offers-EUROIMMUN-Anti-Zika-Virus89,Zika,Siemens Healthcare Diagnostics,Siemens Healthcare Diagnostics,Europe (EURO),Germany,Erlangen,Henkestr. 127,91052,800 20 10 20 22,https://www.healthcare.siemens.com/how-can-we-help-you/email-us,Private,http://www.healthcare.siemens.com/laboratory-diagnostics,,Laboraty Methods,Genetic assay to test for Zika prior to AB production,http://www.businesswire.com/news/home/20160229005657/en/Siemens-Release-Detection-Test-Zika-Virus90,Zika,SD Biosensors,SD Biosensors,Western Pacific (WPRO),South Korea,"Yeongtong-gu, Suwon-si, GyeongGi-do",Floor Digital Empire Building 980-3 Yeongtong-dong,,82-31-300-0477, sales@sdbiosensor.com,Private,http://sdbiosensor.co.kr/?ckattempt=1,,Laboraty Methods,Zika PCR Kit,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf91,Zika,SolGent,SolGent,Western Pacific (WPRO),South Korea,"Yuseong-gu, Daejeon", 692 Gwanpyeong-dong,,82 42-864-5695,,Private,http://www.solgent.com/eng/index.php,,Laboraty Methods,"Zika, Dengue and Chikungunya multiplex PCR kit",http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf92,Zika,Euroimmune,Euroimmune,Europe (EURO),Germany,Luebeck ,Seekamp 31,23560,49 451 5855-0, info@euroimmun.de,Private,https://www.euroimmun.com/startseite.html,,Laboraty Methods,Anti_Zika Virus IIFT (IgM or IgG) utilise Zika virus_infected cells as the antigenic substrate. Positive and negative results are evaluated by fluorescence microscopy.,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf93,Zika,Euroimmune,Euroimmune,Europe (EURO),Germany,Luebeck ,Seekamp 31,23560,49 451 5855-0, info@euroimmun.de,Private,https://www.euroimmun.com/startseite.html,,Laboraty Methods,Anti_Zika Virus ELISA (IgM) provide fully automated antibody detection using microplates coated with a recombinant protein from Zika virus.,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf94,Zika,Euroimmune,Euroimmune,Europe (EURO),Germany,Luebeck ,Seekamp 31,23560,49 451 5855-0, info@euroimmun.de,Private,https://www.euroimmun.com/startseite.html,,Laboraty Methods,Anti_Zika Virus ELISA (IgG) provide fully automated antibody detection using microplates coated with a recombinant protein from Zika virus.,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf95,Zika,Biocan Diagnostics,Biocan Diagnostics,America (AMRO),Canada,"Coquitlam, BC","55A &, 53 B Fawcett Rd",V3K 6V2,1-778-855-1720,sales@rapidtest.ca,Private,http://www.zikatest.com,,Laboraty Methods,Mix of ZIKV NS1 and Envelope protein (for IgM and IgG detection),http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf96,Zika,Biocan Diagnostics,Biocan Diagnostics,America (AMRO),Canada,"Coquitlam, BC","55A &, 53 B Fawcett Rd",V3K 6V2,1-778-855-1720,sales@rapidtest.ca,Private,http://www.zikatest.com,,Laboraty Methods,"Cassette format: Dengue IgG/IgM, NS1 Ag +Chikungunya IgG/IgM Ab + Zika IgG/IgM Combo",http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf97,Zika,Orangelife,Orangelife,America (AMRO),Brazil,Rio de Janeiro,"Estr. dos Bandeirantes, 11742 - Vargem Pequena",22783-551,55 21 3518-5552,contato@orangelife.com.br,Private,http://www.orangelife.com.br,,Laboraty Methods,Ag/Ab based test for Zika,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf98,Zika,NG Biotech Z.A.,NG Biotech Z.A.,America (AMRO),France,Guipry,"ZA Courbouton, secteur 1, Atelier relais le Tremplin",35480,33 2 23 30 17 83,info@ngbiotech.com,Private,http://www.ngbiotech.com/index.php,,Laboraty Methods,Under development: RDT to detect Zika antibodies,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf99,Zika,InBios,InBios,Europe (EURO),United States,"Seattle, WA",562 1st Avenue South #600,98104,(206) 344-5821,info@inbios.com,Private,http://www.inbios.com,,Laboraty Methods,Developing an antigen detection test (during acute/febrile phase and an IgM/IgG test for convalescent phase samples.,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf100,Zika,CureVac,CureVac,America (AMRO),United States,"Cambridge, MA","210 Broadway, Suite 201", 02139,49 7071 9883 - 0, info@curevac.com,Private,http://www.curevac.com,,Vaccine,"mRNA-based vaccine, in exploratory/early development phase ",http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf101,Zika,Profectus Biosciences,Profectus Biosciences,America (AMRO),United States,"Baltimore, MD",6411 Beckley St # 201,21224,(443) 743-1100, presley@profectusbiosciences.net,Private,http://www.profectusbiosciences.com,,Vaccine,Planning/discovery stage,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf102,Zika,Middle Tennessee State University,Middle Tennessee State University,America (AMRO),United States,"Murfreesboro, TN",1301 E Main St,37132,(615) 898-2300,news@mtsu.edu ,Academic,http://www.mtsu.edu,,Therapeutics,Developing ICI406 - an experimental Zika treatment with possible activity against secondary conditions like microcephaly and GBS,http://www.huffingtonpost.ca/jason-tetro/zika-therapy_b_9798906.html103,Zika,Quest Diagnostics,Quest Diagnostics,America (AMRO),United States,"Madison, NJ",3 Giralda Farms,7940,800-222-0446,https://secure.questdiagnostics.com/ViewsFlash/servlet/viewsflash?cmd=page&pollid=contactus!bus_dev,Private,http://questdiagnostics.com/home.html,,Laboraty Methods,Zika Virus RNA Qualitative Real-Time RT-PCR test given FDA Emergency Use Authorization,http://newsroom.questdiagnostics.com/2016-04-28-Zika-Test-from-Quest-Diagnostics-Authorized-by-the-FDA-for-Emergency-Use104,Zika,Ennaid Therapeutics,Ennaid Therapeutics,America (AMRO),United States,Alpharetta,2972B Webb Bridge RD (ATC Innovation Center),30009,678-720-8151,bizdev@ennaidthera.com,Private,http://ennaidtherapeutics.com/science/,,Laboraty Methods," peptide fusion inhibitors show significant inhibition against many Flaviviridae family of viruses, such as Dengue and possibly Zika",http://www.prnewswire.com/news-releases/ennaid-therapeutics-prioritizes-zika-virus-rapid-drug-development-in-wake-of-crisis-300219899.html105,Zika,European Medicines Agency,European Medicines Agency,Europe (EURO),England,London,30 Churchill Pl,E14 5EU,44 20 3660 6000,,Public,http://www.ema.europa.eu/ema/,,Regulator,Set up a task force to provide scientific and regulartory advice on Zika,http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/02/news_detail_002466.jsp&mid=WC0b01ac058004d5c1106,Zika,NIBSC,NIBSC,Europe (EURO),England,"South Mimms, Potters Bar",Blanche Ln,EN6 3QG,44 1707 641000,enquiries@nibsc.org,Public,http://www.nibsc.org/,,Laboraty Methods,N/A,N/A,http://www.fool.com/investing/general/2016/04/16/the-race-to-cure-the-zika-virus-is-on-and-this-com.aspx,,,,,,,,,,,107,Zika,NIH/VRC,NIH/VRC,America (AMRO),United States,"Bethesda, MD",5601 Fishers Lane,20892,866-284-4107,ocpostoffice@niaid.nih.gov,Public,www.vrc.nih.gov,,Vaccine,Using West Nile and dengue vaccines as model for Zika vaccine development,http://www.niaid.nih.gov/about/directors/congress/Documents/NIAID-Zika-Testimony-5-12-2016.pdf108,Zika,Alere,Alere,America (AMRO),United States,"Waltham, MA","51 Sawyer Road, Suite 200",2453,(781) 647-3900,,Private,www.alere.com,,Laboraty Methods,"Developing a Zika diagnostic test, Abbott Labs bought them for $5.8M",http://www.reuters.com/article/us-alere-m-a-abbott-idUSKCN0VA2IM109,Zika,Biomérieux,Biomérieux,America (AMRO),United States,"Durham, NC",100 Rodolphe Street,27712,(800) 682-2666,,Private,http://www.biomerieux-usa.com/,,Laboraty Methods,Developing a Zika diagnostic test,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf110,Zika,Cepheid,Cepheid,America (AMRO),United States,"Sunnyside, CA",904 Caribbean Drive,94089,1-408-541-4191,investor.relations@cepheid.com,Private,http://www.cepheid.com/,Partnering with FIND,Laboraty Methods,Developing a Zika diagnostic test,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf111,Zika,Veterinary Research Institute,Veterinary Research Institute,Europe (EURO),Czech Republic,Brno,Hudcova 296/70,621 00 ,420 5 3333 2501,skrivanek(at)vri.cz,Academic,http://www.vri.cz/,,Laboraty Methods,Identified anti-Zika activity from 2_-C-methylated nucleosides,http://jid.oxfordjournals.org/content/early/2016/05/26/infdis.jiw226.abstract112,Zika,The Czech Academy of Sciences,The Czech Academy of Sciences,Europe (EURO),Czech Republic,Prague,Fleming Sq. 2,16610,420 221 403 111, info@cas.cz,Academic,http://www.avcr.cz/en,,Laboraty Methods,Identified anti-Zika activity from 2_-C-methylated nucleosides,http://jid.oxfordjournals.org/content/early/2016/05/26/infdis.jiw226.abstract113,Zika,University of South Bohemia,University of South Bohemia,Europe (EURO),Czech Republic,_eské Bud_jovice,Brani_ovská 31,37005,420 387 776 201,N/A,Academic,http://www.prf.jcu.cz/en,,Laboraty Methods,Identified anti-Zika activity from 2_-C-methylated nucleosides,http://jid.oxfordjournals.org/content/early/2016/05/26/infdis.jiw226.abstract114,Zika,INSA National Institute of Health Dr. Ricardo Jorge,INSA National Institute of Health Dr. Ricardo Jorge,Europe (EURO),Portugal,Águas de Moura,"Av. da Liberdade, 5",2965-575,(+351) 265 912 155,cevdi@insa.min-saude.pt,Public,http://www.insa.pt/sites/INSA/English/Pages/NationalHealthInstituteDoutorRicardoJorge.aspx,,Laboraty Methods,Identified anti-Zika activity from 2_-C-methylated nucleosides,http://jid.oxfordjournals.org/content/early/2016/05/26/infdis.jiw226.abstract115,Zika,Rega Institute for Medical Research,Rega Institute for Medical Research,Europe (EURO),Belgium,Leuven,Minderbroedersstraat 10,B-3000 ,32 16 33 73 67,N/A,Academic,http://rega.kuleuven.be/,,Laboraty Methods,Identified anti-Zika activity from 2_-C-methylated nucleosides,http://jid.oxfordjournals.org/content/early/2016/05/26/infdis.jiw226.abstract116,Zika,Aix Marseille Université,Aix Marseille Université,Europe (EURO),France,Marseille cedex 07,58 blvd Charles Livon,13284,33 491 396 500,N/A,Academic,http://www.univ-amu.fr/en,,Laboraty Methods,,117,Zika,Crucell Holland B.V.,Crucell Holland B.V.,Europe (EURO),Netherlands,Archimedesweg 4,2301 CA Leiden,P.O. Box 2048,31 71 519 7777,JanssenIDVNL@its.jnj.com,Private,http://www.janssen.com/infectious-diseases-and-vaccines/crucell,,Vaccine,Joined Janssen Pharma and was awarded $28.5M for vaccine development,http://www.avianflutalk.com/jj-parda-evd-vaccine-funding-usd-285mil_topic34935.html118,Zika,GSK Biologicals,GSK Biologicals,America (AMRO),United States,"Philadelphia, PA",5 Crescent Drive,19112,888 825 5249,corporate.media@gsk.com,Private,http://www.gsk.com/,,Vaccine,Preclinical development based on earlier experience with flaviviruses,http://www.glopid-r.org/wp-content/uploads/2016/05/findings-of-zika-research-working-groups-on-vaccines-aetiology-and-diagnostics.pdf119,Zika,Norwegian Institute of Public Health,Norwegian Institute of Public Health,Europe (EURO),Norway,Oslo,PO Box 4404 Nydalen,403,47 21077000,"http://www.fhi.no/eway/default.aspx?pid=239&trg=Left_7048&Main_6157=6261:0:25,5532&MainContent_6261=7047:0:25,8272&Left_7048=6659:103594::0:7049:1:::0:0",Public,http://www.fhi.no/,,Laboraty Methods,Antibody and PCR tests for Zika,"http://www.fhi.no/eway/default.aspx?pid=240&trg=Content_6765&Main_6664=6894:0:25,7555:1:0:0:::0:0&MainContent_6894=6765:0:25,7572:1:0:0:::0:0&Content_6765=6729:118603:25,7572:1:6770:1:::0:0"120,Zika,Imperial College,Imperial College,Europe (EURO),United Kingdom,London,South Kensington Campus,SW7 2AZ,44 (0)20 7589 5111,N/A,Academic,https://www.imperial.ac.uk/,,Vaccine,Recombinant vaccines; currently have efficacy in rodents,http://www.glopid-r.org/wp-content/uploads/2016/05/findings-of-zika-research-working-groups-on-vaccines-aetiology-and-diagnostics.pdf121,Zika,BARDA,BARDA,America (AMRO),United States,"Washington, DC","200 Independence Avenue, S.W. Room 638G",20201,N/A,N/A,Public,,,Funder,"Supporting multiple federal vaccine and diagnostic projects, funding available for private sector",http://www.glopid-r.org/wp-content/uploads/2016/05/findings-of-zika-research-working-groups-on-vaccines-aetiology-and-diagnostics.pdf122,Zika,Biocryst,Biocryst,America (AMRO),United States,"Durham, NC","4505 Emperor Blvd, Suite 200",27703,(919) 859-1302,info@biocryst.com,Private,http://www.biocryst.com/,,Therapeutics,BCX443 tested in mice successfully,http://www.reuters.com/article/us-health-zika-biocryst-pharm-idUSKCN0W91B8123,Zika,Broad Institute,Broad Institute,America (AMRO),United States,"Cambridge, MA",415 Main St.,2142,617-714-7000,https://www.broadinstitute.org/contact,Academic,https://www.broadinstitute.org/,,Laboraty Methods,Rapid low-cost diagnostic test,https://www.broadinstitute.org/publications/broad8188124,Zika,Cayetano Heredia University,Cayetano Heredia University,America (AMRO),Peru,Lima,"Av Honorio Delgado 430, Urb Engineering",N/A,51 1 3190000,portalweb@upch.pe,Academic,http://www.upch.edu.pe/portal/,,Vector Control,Developing methods to kill Zika-carrying viruses,http://www.mb.com.ph/fish-other-mosquitoes-now-warriors-in-zika-battle/125,Zika,Center for Biologics Evaluation and Research (CBER),Center for Biologics Evaluation and Research (CBER),America (AMRO),United States,"SIlver Spring, MD",10903 New Hampshire Avenue Building 71 Room 3103,20993-0002,(800) 835-4709,ocod@fda.hhs.gov,Public,http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CBER/default.htm,,Vaccine,Working with the CDC to accelerate diagnostics for Zika,http://www.raps.org/Regulatory-Focus/News/2016/03/30/24679/FDA-Authorizes-Use-of-Investigational-Diagnostic-to-Screen-Blood-Donors-for-Zika/126,Zika,PaxVax,PaxVax,America (AMRO),United States,Redwood City,"900 Veterans Blvd., Ste. 500",94063,(650) 847-1075,info@paxvax.com,Private,http://www.paxvax.com/,,Vaccine,Early preclinical development,http://www.who.int/csr/research-and-development/zika-rd-pipeline.pdf127,Zika,Novavax,Novavax,America (AMRO),United States,Gaithersburg,20 Firstfield Road,20878,(240) 268-2000,ir@novavax.com,Public,http://novavax.com/,,Vaccine,Exploratory R&D,http://www.fiercepharma.com/r-d/novavax-explores-zika-vaccine-r-d-effort-as-virus-continues-to-spread128,Zika,University of Toronto,University of Toronto,America (AMRO),Canada,Toronto,27 King's College Cir,M5S 1A1,416-978-2011,gradschool@utoronto.ca,Academic,www.utoronto.ca,,Laboraty Methods,Rapid low-cost diagnostic test,https://www.utoronto.ca/news/rapid-low-cost-detection-zika-virus-developed-experts-u-t-harvard-mit-cornell-and-more129,Zika,Walter Reed Army Institute of Research,Walter Reed Army Institute of Research,America (AMRO),United States,"Silver Spring, MD",503 Robert Grant Ave,20910,301-319-9471,usarmy.detrick.medcom-wrair.mbx.public-affairs@mail.mil,Public,http://wrair-www.army.mil,,Vaccine,Whole-particle inactivated Zika vaccine,https://www.niaid.nih.gov/topics/zika/researchapproach/Pages/vaccineResearch.aspx130,Zika,MIT,MIT,America (AMRO),United States,Cambridge,77 Massachusetts Ave,2139,617-253-1000,tele-info@mit.edu.,Academic,http://web.mit.edu/,,Laboraty Methods,Rapid low-cost diagnostic test,http://news.mit.edu/2016/paper-based-test-zika-virus-0506131,Zika,Biotron,Biotron,Western Pacific (WPRO),Australia,"North Ryde, NSW","Box 31, 3/3 Julius Avenue",2113,(61-2) 9805 0488,enquiries@biotron.com.au,Private,http://www.biotron.com.au/,,Laboraty Methods,Developed two compounds that have shown anti-ZIKA activity,http://www.biotron.com.au/wp-content/uploads/2016/05/Biotron-Compounds-Demonstrate-Activity-Against-Zika-Virus.pdf132,Ebola,Public Health Agency of Canada,Public Health Agency of Canada,America (AMRO),Canada,"Ottawa, Ontario","130 Colonnade Road, A.L. 6501H  ",K1A 0K9,1-844-280-5020,http://www.phac-aspc.gc.ca/contac-eng.php,Public,http://www.phac-aspc.gc.ca/index-eng.php?utm_source=VanityURL&utm_medium=URL&utm_campaign=publichealth.gc.ca,,Vaccine,"developer of VSV-EBOV-GP (V920) candidate, uses vesicular stomatis virus ",http://www.phac-aspc.gc.ca/id-mi/vsv-ebov-fs-eng.php133,Ebola,Canadian Immunization Research Network,Canadian Immunization Research Network,America (AMRO),Canada," Halifax, Nova Scotia","PO Box 9700, 5850-5980 University Ave.", B3K 6R8,(902) 470-6968,allison.young@iwk.nshealth.ca,Public,http://cirnetwork.ca,,Vaccine,Conducted Phase I Clincal Trials for rVSV-EBOV-GP alliance,http://www.cihr-irsc.gc.ca/e/49525.html134,Ebola,Merck & Co,Merck,America (AMRO),United States,"Kenilworth, NJ",2000 Galloping Hill Road,7033,908-740-4000,N/A,Private,merck.com,,Vaccine,licensed rVSV- EBOV-GP vaccine candidate from NewLink for further development,http://www.mercknewsroom.com/news-release/ebola-newsroom/phase-iii-trial-merck-and-newlink-genetics-investigational-ebola-vaccine135,Ebola,New Link,New Link,America (AMRO),United States,"Ames, IA",2503 South Loop Drive Suite 5100,50010,515-296-5555,info@newlinkgenetics.com,Private,http://www.newlinkgenetics.com,,Vaccine,further developing rVSV-EBOV-GP vaccine candidate with Merck,http://www.mercknewsroom.com/news-release/ebola-newsroom/phase-iii-trial-merck-and-newlink-genetics-investigational-ebola-vaccine136,Ebola,Epicentre,Epicentre,America (AMRO),United States,"Charlotte, NC ",210 E Trade St ,28202,(608) 258-3080,customerservice@illumina.com,Private,http://www.epibio.com/home,,Vaccine,Financed clinical trials,http://www.who.int/medicines/ebola-treatment/q_a_vaccine_trial_guinea/en/137,Ebola,US Center for Disease Control and Prevention CDC (USA),US Centers for Disease Control and Prevention (CDC),America (AMRO),United States,"Atlanta, GA",1600 Clifton Road,30333,800-CDC-INFO,https://wwwn.cdc.gov/dcs/ContactUs/Form,Public,http://www.cdc.gov,,Vaccine,Clinical trials in Sierra Leone for Ebola,http://www.cdc.gov/vhf/ebola/strive/,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm,,,,,,,,,,,138,Ebola,US Center for Disease Control and Prevention CDC (USA),US Centers for Disease Control and Prevention (CDC),America (AMRO),United States,"Atlanta, GA",1600 Clifton Road,30333,800-CDC-INFO,https://wwwn.cdc.gov/dcs/ContactUs/Form,Public,http://www.cdc.gov,,Laboratory Methods,developing NP Real-Time RT-PCR Assay to detect Ebola,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm139,Ebola,US Center for Disease Control and Prevention CDC (USA),US Centers for Disease Control and Prevention (CDC),America (AMRO),United States,"Atlanta, GA",1600 Clifton Road,30333,800-CDC-INFO,https://wwwn.cdc.gov/dcs/ContactUs/Form,Public,http://www.cdc.gov,,Laboratory Methods,devloping VP40 Realtime RT-PCR Assay to detect Ebola,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm140,Ebola,US Department of Defense,US Department of Defense,America (AMRO),United States,"Washington, DC",1400 Defense Pentagon,20301,703-571-3343,public.affairs@dodig.mil,Public,www.defense.gov,,Vaccine,"Collaborated in Phase I, II, and III for EBOV",http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf141,Ebola,Department of Defense ,Department of Defense ,America (AMRO),United States,"Washington, DC",1400 Defense Pentagon,20301,703-571-3343,public.affairs@dodig.mil,Public,www.defense.gov,,Laboratory Methods,devloping EZ1 Real-time RT-PCR Assay to detect Ebola,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm142,Ebola,Biomedical Advanced Research and Development Authority (BARDA),Biomedical Advanced Research Development Authority (BARDA),America (AMRO),United States,"Washington, D.C. ","200 Independence Avenue, S.W., Room 638G ",20201, 202-205-8114,Gretchen.Michael@hhs.gov,Public,http://www.phe.gov/about/BARDA/Pages/default.aspx,,Vaccine,"Collaborated in Phase I, II, and III for EBOV",http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf143,Ebola,National Institutes of Health,National Institutes of Health,America (AMRO),United States,"Bethesda, MD",9000 Rockville Pike,20892,301-496-4000, NIHinfo@od.nih.gov,Public,nih.gov,,Vaccine,"Collaborated in Phase I, partnered with NIAID and Liberia for Phase III",http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf144,Ebola,Walter Reed Army Institute of Research,Walter Reed Army Institute of Research,America (AMRO),United States,"Silver Spring, MD",503 Robert Grant Ave ,20910,301-319-9471,usarmy.detrick.medcom-wrair.mbx.public-affairs@mail.mil,Public,http://wrair-www.army.mil,ISARIC,Vaccine,"Collaborated in Phase I, II, and III for EBOV",http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf145,Ebola,US Army Medical Research Institute of Infectious Diseases (USAMRIID),US Army Medical Research Institute of Infectious Diseases (USAMRIID),America (AMRO),United States,"Frederick, MD","Attn: MCMR-UIZ-R, 1425 Porter Street",21702-5011,(301) 619-2285,teresa.l.vanderlinden.civ@mail.mil,Public,http://www.usamriid.army.mil,ISARIC,Vaccine,"Collaborated in Phase I, II, and III for EBOV",http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf146,Ebola,WHO,WHO,Europe (EURO),Switzerland,Geneva 27,Avenue Appia 20,1211,41 22 791 21 11,http://www.who.int/about/contact_form/en/,Public,http://www.who.int/en/,,All,"Clinical consortium collaborated for Phase I, helped in Guinea for Phase II/III",http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf147,Ebola,Medicens sans Frontieres,Medicens sans Frontieres,Europe (EURO),Switzerland,Geneva 21,"78 rue de Lausanne, Case Postale 116",1211,41 22 849 8484,N/A,NGO ,http://www.msf.org,,All,Collaborated in Phase II/III in Guinea,http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf148,Ebola,Wellcome Trust,Wellcome Trust,Europe (EURO),United Kingdom,London,"Gibbs Building, 215 Euston Road",NW1 2BE,44 (0)20 7611 8888,contact@wellcome.ac.uk,Public,http://www.wellcome.ac.uk,GloPID-R,Funder,Led funding consortium for Phase I,http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf149,Ebola,Norweigan Institute of Public Health,Norweigan Institute of Public Health,Europe (EURO),Norway,Oslo,PO Box 4404 Nydalen,403,47 21077000,"http://www.fhi.no/eway/default.aspx?pid=239&trg=Left_7048&Main_6157=6261:0:25,5532&MainContent_6261=7047:0:25,8272&Left_7048=6659:103594::0:7049:1:::0:0",Public,http://www.fhi.no/eway/default.aspx?pid=240,,Funder,Collaborated in Phase II/III in Guinea,http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf150,Ebola,Ministry of Health of Guinea,Ministry of Health of Guinea,Africa (AFRO),Guinea,Conakry,N/A,N/A,N/A,N/A,Public,N/A,,All,Collaborated for Phase II and III clinical trials,http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf151,Ebola,Partnership for Research on Ebola Vaccines in Liberia,Partnership for Research on Ebola Vaccines in Liberia,Africa (AFRO),Liberia/United Sates/United Kingdom,Multiple,Multiple,N/A,N/A,N/A,Academic/Public/Private,N/A,,Vaccine,Collaborated with NIH (NIAID) for Phase II and III Clinical Trials,http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf152,Ebola,Sierra Leone College of Medicine and Allied Health Sciences,Sierra Leone College of Medicine and Allied Health Sciences,Africa (AFRO),Sierra Leone,Freetown,"University Secretariat Building, A.J. Momoh Street, Tower Hill",N/A,232 33 80522,info@usl.edu.sl,Academic,http://www.usl.edu.sl/?page_id=786,,All,Collaborated with CDC for Phase II and III clinical trials,http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf153,Ebola,Sierra Leone Ministry of Health and Sanitation,Sierra Leone Ministry of Health and Sanitation,Africa (AFRO),Sierra Leone,Freetown,4th Floor Youyi Building,N/A,23278849998,tunis@health.gov.sl,Public,,,All,Collaborated with CDC for Phase II and III clinical trials,http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf154,Ebola,Clinical Trial Center North at University of Hamburg - Eppendorf,Clinical Trial Center North at University of Hamburg - Eppendorf,Europe (EURO),Germany,Hamburg,Martinistraße 64,20251,+49 (0)40 524719-0,info@ctc-north.com,Academic,https://www.ctc-north.com/cms/en.html,,Laboratory Methods,Collaborated for Phase I clinical trials of rVSV,http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf155,Ebola,University of Geneva,University of Geneva,Europe (EURO),Switzerland,Genève 4,4 rue du Général-Dufour ,1211,+41 22 379 77 17,communication@unige.ch ,Academic,http://www.unige.ch/,,Vaccine,Collaborated for Phase I clinical trials of rVSV,http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf156,Ebola,BioCryst Pharmaceuticals,BioCryst Pharmaceuticals,America (AMRO),United States,"Durham, NC","4505 Emperor Blvd, Suite 200",27703,(919) 859-1302,info@biocryst.com,Private,http://www.biocryst.com/,,Therapeutics,Phase I clinical trials for BCX4430,https://clinicaltrials.gov/ct2/show/NCT02319772157,Ebola,National Institute of Allergies and Infectious Diseases (NIAID),National Institute of Allergy and Infectious Diseases (NIAID),America (AMRO),United States,"Bethesda, MD","5601 Fishers Lane, MSC 9806", 20892-9806,866-284-4107,ocpostoffice@niaid.nih.gov,Public,https://www.niaid.nih.gov/Pages/default.aspx,,Funder,Contracted BioCryst for early R&D in 2013,http://www.cidrap.umn.edu/news-perspective/2015/03/biocryst-gets-hhs-contract-ebola-drug-development158,Ebola,Biomedical Advanced Research and Development Authority (BARDA),Biomedical Advanced Research and Development Authority (BARDA),America (AMRO),United States,"Washington, DC","200 Independence Avenue, S.W., Room 638G",20201, 202-205-8114,Gretchen.Michael@hhs.gov,Public,http://www.phe.gov/about/BARDA/Pages/default.aspx,,Funder,Provided BioCryst with a $12 million grant,http://www.cidrap.umn.edu/news-perspective/2015/03/biocryst-gets-hhs-contract-ebola-drug-development159,Ebola,Inovio Pharmaceuticals,Inovio Pharmaceuticals,America (AMRO),United States,"Plymouth Meeting, PA",660 West Germantown Pike Suite 110,19462,267.440.4200, clinical.trials@inovio.com,Private,http://www.inovio.com,,Vaccine,Phase I study for INO-4212,https://clinicaltrials.gov/ct2/show/NCT02464670160,Ebola,Defense Advanced Research Projects Agency (DARPA),Defense Advanced Research Projects Agency (DARPA),America (AMRO),United States,"Arlington, VA",675 North Randolph Street,22203-2114,(703) 526-6630, outreach@darpa.mil,Public,http://www.darpa.mil/,,Funder,Awarded Inovio $24 million for EBOV vaccine ,http://ir.inovio.com/news/news-releases/news-releases-details/2015/Inovio-Receives-24-Million-Option-Grant-From-DARPA-to-Advance-Ebola-Program-Development/default.aspx161,Ebola,MedImmune,MedImmune,America (AMRO),United States,"Gaithersburg, MD ",1 MedImmune Way,20878, 301-398-1468,GetInTouch@MedImmune.com,Private,https://www.medimmune.com/,,Therapeutics,Manufactured protein mABs for INO-4212,http://ir.inovio.com/news/news-releases/news-releases-details/2015/Inovio-Pharmaceuticals-Selected-by-DARPA-to-Lead-a-45-Million-Program-to-Expedite-Development-of-Novel-Products-to-Prevent-and-Treat-Disease-Caused-by-Ebola/162,Ebola,University of Pennsylvania,University of Pennsylvania,America (AMRO),United States,"Philadelphia, PA",N/A,19104,(215) 898-5000,regist@pobox.upenn.edu,Academic,http://www.upenn.edu/,,Vaccine,Collaborating with development and clinical trials,http://ir.inovio.com/news/news-releases/news-releases-details/2015/Inovio-Pharmaceuticals-Selected-by-DARPA-to-Lead-a-45-Million-Program-to-Expedite-Development-of-Novel-Products-to-Prevent-and-Treat-Disease-Caused-by-Ebola/163,Ebola,GeneOne Life Sciences,GeneOne Life Sciences,Western Pacific (WPRO),South Korea,Seoul,"Suite 1903, 223 Teheran-Ro, Gangnam-Gu",6142,82.2.527.0600,genels@genels.com,Private,http://www.genels.com,,Vaccine,Co-developed DNA-based vaccine with Inovio,http://ir.inovio.com/news/news-releases/news-releases-details/2014/Inovio-Pharmaceuticals-Ebola-Vaccine-Moving-into-Human-Trial-with-GeneOne-Life-Science/default.aspx164,Ebola,Johnson & Johnson,Johnson & Johnson,America (AMRO),United States,"New Brunswick, New Jersey",One Johnson & Johnson Plaza,08933,(732) 524-0400,https://www.ccc-consumercarecenter.com/universal-contact-us/us-jnj-ucu/www.jnj.com,Private,http://www.jnj.com,,Vaccine,Accelerated Phase I and II EBOV studies in Sierra Leone - EBOVAC-Salone,http://www.jnj.com/news/all/johnson-johnson-announces-start-of-clinical-trial-of-ebola-vaccine-regimen-in-sierra-leone165,Ebola,Bavarian Nordic,Bavarian Nordic,Europe (EURO),Denmark,Kvistgaard,Hejreskovvej 10A,DK-3490 ,45 33 26 83 83,info@bavarian-nordic.com,Private,http://www.bavarian-nordic.com/,,Vaccine,MVA-BN filovirus vaccine collaboration with J&J,http://www.bioworld.com/content/johnson-johnson-bavarian-nordic-ink-187m-deal-ebola-virus-vaccine166,Ebola,Innovative Medicines Initiative,Innovative Medicines Initiative,Europe (EURO),Belgium,Brussells,Avenue de la Toison d'Or 56-60,B-1060 ,32 (0)2-221 81 81,INFODESK (at) imi.europa.eu,Public/Private,https://www.imi.europa.eu/content/home,,Funder,$200 million in funding allocated for 8 projects,http://www.imi.europa.eu/content/ebola-programme#aboutEbola167,Ebola,National Institute of Allergies and Infectious Diseases (NIAID),National Institute of Allergy and Infectious Diseases,America (AMRO),United States,"Bethesda, MD","5601 Fishers Lane, MSC 9806",20892-9806,866-284-4107,ocpostoffice@niaid.nih.gov,Public,https://www.niaid.nih.gov/Pages/default.aspx,,Vaccine,Collaborated with NIH and Liberia for rVSV clinical trials,http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf168,Ebola,University of Oxford,University of Oxford,Europe (EURO),United Kingdom,Oxford,Wellington Square,OX1 2JD,44 1865 270000,N/A,Academic,http://www.ox.ac.uk/,,Vaccine,EBOVAC2 collaboration with J&J,http://www.ox.ac.uk/news/2015-07-15-oxford-ebola-vaccine-study-moves-next-phase169,Ebola,Institut de microbiologie et des maladies infectieuses (INSERM),Institut de microbiologie et des maladies infectieuses (INSERM),Europe (EURO),France,N/A,N/A,N/A,N/A,http://www.inserm.fr/contact,Public/Private/Academic,http://english.inserm.fr/,,Vaccine,Coordinating recruitment for clinical trials,http://presse.inserm.fr/en/inserm-recruiting-about-300-volunteers-to-test-vaccine-against-the-ebola-virus/21714/170,Ebola,Grameen Foundation,Grameen Foundation,America (AMRO),United States,"Washington, DC","1101 15th St. NW, 3rd Floor",20005,202-628-3560,http://www.grameenfoundation.org/contact,Non-profit,http://www.grameenfoundation.org/,,Vaccine,Coordinating clinical trials using telehealth,http://www.scidev.net/global/medicine/news/mobile-phones-ebola-vaccine-trials.html171,Ebola,World Vision of Ireland,World Vision of Ireland,Europe (EURO),Ireland,Dublin,"World Vision Ireland, The Mews,Garland House, Rathmines Park, Dublin 6 ",D06 C6K4,353-1-498 0800,ireland@wvi.org,Non-profit,http://www.worldvision.ie/,,Vaccine,Received IMI grant to work communications strategy for Ebola vaccine,http://www.worldvision.ie/press-centre/detail/world-vision-ireland-to-play-a-key-role-in-ebola-vaccine-programme172,Ebola,London School of Hygiene & Tropical Medicine,London School of Hygiene & Tropical Medicine,Europe (EURO),United Kingdom,London,Keppel St,WC1E 7HT,44 (0) 20 7636 8636,press@lshtm.ac.uk,Academic,http://www.lshtm.ac.uk/,,Vaccine,Coordinating clinical trials in Sierra Leone,http://www.lshtm.ac.uk/newsevents/news/2015/ebola_vaccine_trial_underway.html173,Ebola,University of Bordeaux,University of Bordeaux,Europe (EURO),France,Bordeaux Cedex, 3 Ter Place de la Victoire,33000,33 5 57 57 10 10,incoming-carreire@u-bordeaux.fr,Academic,http://www.u-bordeaux.com/Education/Welcome-contacts/Bordeaux-Campus,,Therapeutics,Clinical trial platform for EBOVAC2,http://www.inria.fr/en/centre/bordeaux/news/developing-a-new-ebola-vaccine174,Ebola,Le Centre Muraz,Le Centre Muraz,Africa (AFRO),Burkina Faso,Bobo-Dioulasso,"2054 Avenue Mamadou Konate,  Bobo-Dioulasso 01",01 BP 390,N/A,N/A,Academic,N/A,,Vaccine,AD26ZEBOV clinical trial help,http://www.aib.bf/m-4385-prevention-de-la-maladie-a-virus-ebola-le-centre-muraz-va-tester-un-vaccin-.html175,Ebola,GlaxoSmithKline,GlaxoSmithKline,Europe (EURO),United Kingdom," Brentford,Middlesex",980 Great West Road,TW8 9GS,44 (0)20 8990 9000,N/A,Private,N/A,,Vaccine,"ChAd3-ZEBOV vaccine, Phase II and III",http://www.gsk.com/en-gb/media/press-releases/2015/major-milestone-for-gsknih-candidate-ebola-vaccine-as-first-doses-shipped-to-liberia-for-use-in-phase-iii-clinical-trial/176,Ebola,University of Oxford,University of Oxford,Europe (EURO),United Kingdom,Oxford,Wellington Square,OX1 2JD,44 1865 270000,N/A,Academic,http://www.ox.ac.uk/,,Vaccine,EBOVAC2 collaboration with J&J,http://www.ox.ac.uk/news/2015-07-15-oxford-ebola-vaccine-study-moves-next-phase177,Ebola,Public Health Agency of Canada,Public Health Agency of Canada,America (AMRO),Canada,"Ottawa, Ontario","130 Colonnade Road, A.L. 6501H  ",K1A 0K9,1-844-280-502,http://www.phac-aspc.gc.ca/contac-eng.php#general,Public,http://www.phac-aspc.gc.ca/index-eng.php,,Therapeutics,Development of Zmapp,http://www.macleans.ca/society/health/scientists-at-canadas-national-lab-created-tested-ebola-drug-zmapp/178,Ebola,Makerere University,Makerere University,Africa (AFRO),Uganda,Kampala,P.O. Box 7062,N/A,N/A,pro@admin.mak.ac.ug,Academic,http://vc.mak.ac.ug/index.php,,Vaccine,Designed paper test for detection of Ebola,http://allafrica.com/stories/201601220458.html179,Ebola,U.S. Military HIV Research Program,U.S. Military HIV Research Program,America (AMRO),United States,"Bethesda, MD","6720A Rockledge Drive, Suite 400",20817,301-500-3600,info@hivresearch.org,Public,http://www.hivresearch.org/,,Funder,Leveraged resources in West Africa to coordinate clinical trials,http://www.hivresearch.org/ebola-studies180,Ebola,Walter Reed Army Institute of Research,Walter Reed Army Institute of Research,America (AMRO),United States,"Silver Spring, MD",503 Robert Grant Ave ,N/A,301-319-9471,usarmy.detrick.medcom-wrair.mbx.public-affairs@mail.mil,Public,http://wrair-www.army.mil/,,Vaccine,"Collaborated in Phase I, partnered with NIAID and Liberia for Phase III",http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf181,Ebola,Center for Vaccine Development: University of Maryland,Center for Vaccine Development: University of Maryland,America (AMRO),United States,"Baltimore, MD","685 West Baltimore Street , Room 480, Baltimore, MD", 21201-1509,410-706-5328 ,cmartin@medicine.umaryland.edu,Academic,http://medschool.umaryland.edu/CVD/contact.asp,,Vaccine,Clinical trials in Mali and USA,http://somvweb.som.umaryland.edu/absolutenm/templates/?z=41&a=3213182,Ebola,National Institute of Allergies and Infectious Diseases (NIAID),National Institute of Allergy and Infectious Diseases,America (AMRO),United States,"Bethesda, MD","5601 Fishers Lane, MSC ",20892-9806,866-284-4107,ocpostoffice@niaid.nih.gov,Public,https://www.niaid.nih.gov/Pages/default.aspx,,Vaccine,"Collaborated in Phase I, partnered with NIH and Liberia for Phase III",http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf183,Ebola,University Hospital of Lausanne,University Hospital of Lausanne,Europe (EURO),Switzerland,Lausanne,Rue du Bugnon 46,1011,41 21 314 1111,https://forms.chuv.ch/chuv/chuv_home/contact-formulaire.htm,Academic,http://www.chuv.ch/,,Vaccine,ChAd3-ZEBOV vaccine clinical trial at the hospital,http://www.who.int/mediacentre/news/statements/2014/swissmedic-ebola-vaccine/en/184,Ebola,US Army Medical Research Institute of Infectious Diseases (USAMRIID),US Army Medical Research Institute of Infectious Diseases (USAMRIID),America (AMRO),United States,"Frederick, MD","Attn: MCMR-UIZ-R, 1425 Porter Street",21702-5011,(301) 619-2285,teresa.l.vanderlinden.civ@mail.mil,Public,http://www.usamriid.army.mil,,Vaccine,"Collaborated in Phase I, II, and III for EBOV",http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM448006.pdf185,Ebola,Mapp Biopharmaceuticals,Mapp Biopharmaceuticals,America (AMRO),United States,"San Diego,CA",6160 Lusk Blvd. # C10,92121,N/A,admin@mappbio.com,Private,http://mappbio.com/,,Therapeutics,"Created ZMapp, a therapeutics monoclonal antibody cocktail to treat Ebola",http://abcnews.go.com/Business/meet-tiny-company-experimental-drug-ebola/story?id=24838694186,Ebola,Biomedical Advanced Research and Development Authority (BARDA),Biomedical Advanced Research and Development Authority (BARDA),America (AMRO),United States,"Washington, D.C. ","200 Independence Avenue, S.W., Room 638G ",20201, 202-205-8114,Gretchen.Michael@hhs.gov,Public,http://www.phe.gov/about/BARDA/Pages/default.aspx,,Funder,"Funded various vaccine development efforts (rVSV, BioCryst)",http://investors.linkp.com/releasedetail.cfm?releaseid=966557187,Ebola,Bill and Melinda Gates Foundation,Bill and Melinda Gates Foundation,America (AMRO),United States,"Seatle, WA",500 Fifth Avenue North,98109,(206) 709-3100,info@gatesfoundation.org,Non-profit,http://www.gatesfoundation.org/,,Funder,Commits $50 million to support Ebola,http://www.gatesfoundation.org/Media-Center/Press-Releases/2014/09/Gates-Foundation-Commits-$50%20Million-to-Support-Emergency-Response-to-Ebola188,Ebola,Defyrus Inc,Defyrus Inc,America (AMRO),United States,"Toronto, Ontario","2 Bloor Street West, Suite 2602  ",M4W 3E2,(613) 674-1138,info@defyrus.com,Private,http://defyrus.com/,,Therapeutics,"Developed ZMAb, which would be incorporated into ZMapp R&D",http://www.defyrus.com/products_ebola-zmab.html189,Ebola,Yisheng,Yisheng,Western Pacific (WPRO),China,"Beijing, Daxing District","Tianfu Avenue, Building 910, Room 309",N/A,8610-61253655,N/A,Private,http://www.yishengbio.com/,,Vaccine,Working with USAMRIID to use double stranded RNA to make an Ebola vaccine,http://www.prnewswire.com/news-releases/yisheng-biopharma-and-the-united-states-army-medical-research-institute-of-infectious-diseases-announce-collaboration-on-new-vaccine-against-ebola-virus-300191702.html190,Ebola,University of Queensland,University of Queensland,Western Pacific (WPRO),Austrailia,"Brisbane, Queensland",St Lucia,4072,61 7 3365 1111,https://www.uq.edu.au/contacts/,Academic,https://www.uq.edu.au,,Laboratory Methods,Preclinical work with the Kunjin virus vector for Ebola,https://www.uq.edu.au/news/article/2015/03/australian-virus-might-be-answer-effective-ebola-vaccine191,Ebola,QIMR Berghofer Medical Research Institute,QIMR Berghofer Medical Research Institute,Western Pacific (WPRO),Austrailia,"Herston, Queensland",300 Herston Rd ,4006,07 3362 0222,enquiries@qimrberghofer.edu.au,Academic,http://www.qimrberghofer.edu.au/,,Laboratory Methods,Collaborating with the University of Queensland,https://www.uq.edu.au/news/article/2015/03/australian-virus-might-be-answer-effective-ebola-vaccine192,Ebola,University of Lyon,University of Lyon,Europe (EURO),France,Lyon,92 rue Pasteur ,69361,33 (0)4 37 37 26 70,contact@universite-lyon.fr,Academic,http://lyon-university.org/,,Laboratory Methods,Working to understand pathogenicity,http://www.univ-lyon1.fr/research/the-ciri-is-at-the-forefront-in-fighting-the-ebola-virus-816124.kjsp193,Ebola,Université Claude Bernard Lyon 1,Université Claude Bernard Lyon 1,Europe (EURO),France,Villeurbanne,43 Boulevard du 11 Novembre 1918,69100,33-437-2824-50,service.communication@univ-lyon1.fr,Academic,http://www.univ-lyon1.fr/home-759942.kjsp,,Laboratory Methods,Understanding the immune response prompted by Ebola,http://www.univ-lyon1.fr/news/an-ebola-virus-protein-can-cause-massive-inflammation-and-leaky-blood-vessels-772517.kjsp194,Ebola,Biofire Defense LLC,Biofire Defense LLC,America (AMRO),United States,"Murray, UT",79 4500 S Suite 14,84107,(801) 262-3592,info@biofiredefense.com,Private,biofiredefense.com,,Laboratory Methods,Developing FilmArray NGDS BT-E Assay for Ebola detection,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm195,Ebola,Altona Diagnostics,Altona Diagnostics,Europe (EURO),Germany,Hamburg,Mörken strasse. 12,22767,49 40 548 06 76 - 0,info@altona-diagnostics.com,Private,http://www.altona-diagnostics.com/history.html,,Laboratory Methods,Developing RealStar Ebolavirus RT-PCR Kit,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm196,Ebola,Roche Molecylar Systems,Roche Molecylar Systems,America (AMRO),United States,"Pleasanton, CA", 4300 Hacienda Dr,94588,(925) 730-8200,http://molecular.roche.com/static/Pages/Contact.aspx,Private,http://molecular.roche.com/Pages/default.aspx,,Laboratory Methods,Devloping LightMix Ebola Zaire rRT-PCR Test,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm197,Ebola,Corgenix,Corgenix,America (AMRO),United States,"Broomfield, Colorado",11575 Main St #400,80020,(303) 457-4345,info@corgenix.com,Private,http://www.corgenix.com,,Laboratory Methods,Devloping ReEBOV Antigen Rapid Test,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm198,Ebola,Cepheid,Cepheid,America (AMRO),United States,"Sunnyvale, California",904 Caribbean Drive,94089,1-408-541-4191,investor.relations@cepheid.com,Private,http://www.cepheid.com,,Laboratory Methods,Developing Xpert Ebola Assay,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm199,Ebola,"OraSure Technologies, Inc","OraSure Technologies, Inc",America (AMRO),United States,Pennslyvania,220 East First Street,18015,1-800-869-3538,media@orasure.com,Private,http://www.orasure.com,,Laboratory Methods,Devloping OraQuick EBola Rapid Antigen Test for use with whole blood,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm200,Ebola,US Center for Disease Control and Prevention CDC (USA),US Centers for Disease Control and Prevention (CDC),America (AMRO),United States,"Atlanta, GA",1600 Clifton Road,30333,800-CDC-INFO,https://wwwn.cdc.gov/dcs/ContactUs/Form,Public,http://www.cdc.gov,,Laboratory Methods,Developing NP Real-Time RT-PCR Assay to detect Ebola,http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm201,Ebola,Janssen Diagnostics,Janssen Diagnostics,America (AMRO),Belgium,Beerse,Turnhoutseweg 30,2340,32 14 64 1332,N/A,Private,http://www.janssen.com/,,Laboratory Methods,Developed Idylla™ Ebola Virus Triage Test,http://www.jnj.com/news/all/New-Idylla-Ebola-Virus-Triage-Test-Granted-Emergency-Use-Authorization-by-US-FDA202,Ebola,Texas Biomedical Research Institute (Davey Lab),Texas Biomedical Research Institute (Davey Lab),America (AMRO),United States,"San Antonio, TX",P.O. Box 760549,78245-0549,(210) 258-9400,rdavey@txbiomed.org,Academic,https://www.txbiomed.org,,Laboratory Methods,"Developed safe, efficient, high-throughput screening techniques for Ebola virus and performs contract work on testing drugs and compounds against Ebola virus infection in the BSL-4 maximum containment laboratory",https://www.txbiomed.org/scientists/robert-davey/203,Ebola,Texas Biomedical Research Institute (Patterson Lab),Texas Biomedical Research Institute (Patterson Lab),America (AMRO),United States,"San Antonio, TX",P.O. Box 760549,78245-0549,(210) 258-9400,jpatters@txbiomed.org,Academic,https://www.txbiomed.org,,Vaccine,"Involved in development of three vaccines against Ebola, one with Emory University, one with Crucell (Janssen Pharmaceuticals), and one with Bavarian Nordic, all of which are undergoing further studies",https://www.txbiomed.org/scientists/jean-patterson/204,Lassa,University of Maryland School of Medicine (Salvato Lab),University of Maryland School of Medicine (Salvato Lab),America (AMRO),United States,"Baltimore, MD","750 W. Lombard Street, 515",21201,(410) 706-1364,msalvato@ihv.umaryland.edu,Academic,http://medschool.umaryland.edu/,,Vaccine,Lassa fever vaccine research has resulted in two live-attenuated candidates,http://medschool.umaryland.edu/facultyresearchprofile/viewprofile.aspx?id=7743205,Lassa,NIH,NIH,America (AMRO),United States,"Bethesda, Maryland",9000 Rockville Pike,20892,301-496-4000, NIHinfo@od.nih.gov,Public,nih.gov,,Funder,Funding research on Lassa Fever genome,https://www.niaid.nih.gov/news/newsreleases/2015/Pages/LassaGenomes.aspx206,Lassa,Southwest Foundation for Biomedical Research,Southwest Foundation for Biomedical Research,America (AMRO),United States,"San Antonio, TX",N/A,N/A,N/A,N/A,Academic,N/A,,Laboratory Methods,,207,Lassa,Medigen Inc ,Medigen Inc ,America (AMRO),United States,"Frederick, MD","8420 Glass House Pike, Suite S",21701,N/A,info@medigen-usa.com,Private,http://medigen-usa.com/,,Vaccine,Develops two vaccines against Lassa fever for different population groups - (1) live vaccine ML29 for healthy adults and (2) patients with compromised immune functons,http://medigen-usa.com/vaccines208,Lassa,SAFC Pharma ,SAFC Pharma ,America (AMRO),United States,"Carlsbad, CA",6219 El Camino Real,92009,760-710-6100,N/A,Private,http://www.sigmaaldrich.com/safc/facilities/carlsbad-california.html,,Vaccine,Manufacuring YF17D-based Lassa Fever vaccine,http://louisville.edu/predictivemedicine/about/pdf-files/yellow-fever-lassa-project209,Lassa,University of Buenos Aires,University of Buenos Aires,America (AMRO),Argentina,"Buenos Aires, ",Viamonte 430,1053,54 11 4510-1100,N/A,Academic,www.uba.ar,,Vaccine,Developing LF vaccine with the University of Maryland,http://louisville.edu/predictivemedicine/about/pdf-files/yellow-fever-lassa-project210,Lassa,Unite de Biologie des Infectious Virales Emergentes ,Unite de Biologie des Infectious Virales Emergentes ,Europe (EURO),France,Paris,25-28 Rue du Docteur Roux,N/A,N/A,N/A,Academic,https://research.pasteur.fr/fr/project/biology-of-viral-emerging-infections/,,Vaccine,Studying Lassa Fever and how it infects human cells for development of vaccine candidate,https://research.pasteur.fr/fr/project/biology-of-viral-emerging-infections/211,Lassa,Leiden University Medical Center,Leiden University Medical Center,Europe (EURO),Netherlands,Leiden,PO Box 9600,2300 RC,(071) 526 91 11,N/A,Private,https://www.lumc.nl,,Vaccine,Collaborating with University of Maryland researchers for LF vaccine ,http://louisville.edu/predictivemedicine/about/pdf-files/yellow-fever-lassa-project212,Lassa,Andersen Lab (Scripps Research Institute),Andersen Lab (Scripps Research Institute),America (AMRO),United States,"La Jolla, CA","10550 North Torrey Pines Road, SGM-300A",92037,(858) 784-2473, info@andersen-lab.com,Academic,http://andersen-lab.com/,Viral Hemorrhagic Fever Consortium,Laboratory Methods,Using infectious disease genomics to investigate the interaction between the human host and highly pathogenic viruses such as Ebola and Lassa,http://vhfc.org/consortium/partners213,Lassa,Ollman Saphire Lab (Scripps Research Institute),Ollman Saphire Lab (Scripps Research Institute),America (AMRO),United States,"La Jolla, CA","10550 North Torrey Pines Road, IMM 21",92037,(858) 784-8602, erica@scripps.edu,Academic,http://www.scripps.edu/ollmann-saphire/,Viral Hemorrhagic Fever Consortium,Laboratory Methods,Focuses on the production and crystallization of glycoproteins and antibodies that play key roles in the pathogenesis and lethality of hemorrhagic fever viruses,http://vhfc.org/consortium/partners214,Lassa,Oldstone Lab (Scripps Research Institute),Oldstone Lab (Scripps Research Institute),America (AMRO),United States,"La Jolla, CA",10550 North Torrey Pines Road,92037, (858) 784-1000,N/A,Academic,http://www.scripps.edu/oldstone/,Viral Hemorrhagic Fever Consortium,Laboratory Methods,"Interested in understanding the molecular basis of how viruses infect cells, how the immune response aborts viruses, how viruses wrestle control away from the immune system to establish persistent infections, how persistent infection is initiated and maintained, and the mechanism of how such infections cause disease",http://vhfc.org/consortium/partners215,Lassa,Tulane University,Tulane University,America (AMRO),United States,"New Orleans, LA",6823 St. Charles Avenue,70118,504-865-5000,N/A,Academic,http://tulane.edu/,Viral Hemorrhagic Fever Consortium,Laboratory Methods,Working to treat and prevent Lassa fever,http://vhfc.org/consortium/partners216,Lassa,Harvard University (Sabetti Lab),Harvard University (Sabetti Lab),America (AMRO),United States,"Cambridge, MA",52 Oxford Street,(0)2138,N/A,N/A,Academic,http://www.sabetilab.org/,Viral Hemorrhagic Fever Consortium,Laboratory Methods,"Carrying out in-depth genomic analysis and diversity studies, elucidating regions of selection and identifying novel strains of Lassa Fever",http://www.sabetilab.org/research/#infectious217,Lassa,Broad Institute,Broad Institute,America (AMRO),United States,"Cambridge, MA",415 Main Street,(0)2142, 617-714-7000,http://www.broadinstitute.org/contact,Academic,http://www.broadinstitute.org/,Viral Hemorrhagic Fever Consortium,Laboratory Methods,"Systematically defining the components in both pathogens and their hosts that enable pathogens to cause disease, knowledge that will bolster efforts to develop effective vaccines, rapid diagnostics, and new kinds of therapeutics",http://vhfc.org/consortium/partners/harvard218,Lassa,Kenema Government Hospital,Kenema Government Hospital,Africa (AFRO),Sierra Leone,Kenema,N/A,N/A,N/A,N/A,Public,N/A,Viral Hemorrhagic Fever Consortium,Laboratory Methods,Working with others in consortium to develop Lassa Fever treatments and diagnostic,http://vhfc.org/consortium/partners/kgh219,Lassa,Irrua Specialist Teaching Hospital,Irrua Specialist Teaching Hospital,Africa (AFRO),Nigeria,"Irrau, Edo","KM 87, Benin Auchi Road",P.M.B. 08,(234)8058065577,info@isth.com.ng,Academic,http://www.isth.com.ng/,Viral Hemorrhagic Fever Consortium,Laboratory Methods,Increasing capacity to control the epidemic and researching the pathogen,http://vhfc.org/consortium/partners/isth220,Lassa,Autoimmune Technologies,Autoimmune Technologies,America (AMRO),United States,"New Orleans, LA","830 Union Street, Suite 200",70112,(504) 529-9944,mailbox@autoimmune.com,Private,http://www.autoimmune.com/,Viral Hemorrhagic Fever Consortium,Laboratory Methods,Working with others in consortium to develop Lassa Fever treatments and diagnostic,http://www.autoimmune.com/lassagen.html221,Lassa,Corgenix,Corgenix,America (AMRO),United States,"Broomfield, CO",11575 Main Street Suite 400,80020,303-457-4345,info@corgenix.com,Private,http://www.corgenix.com/,Viral Hemorrhagic Fever Consortium,Laboratory Methods,Developed Rapid Diagnostic Test for Lassa Fever,http://www.corgenix.com/news-releases/corgenix-tulane-and-viral-hemorrhagic-fever-consortium-publish-promising-results-from-lassa-fever-trial/222,Lassa,University of Texas Medical Branch,University of Texas Medical Branch,America (AMRO),United States,"Galveston, TX",301 University Blvd,77555,(409) 772-1011, public.affairs@utmb.edu,Academic,http://www.utmb.edu,Viral Hemorrhagic Fever Consortium,Vaccine,The Geisbert laboratory focuses on using recombinant vesicular stomatitis virus (rVSV) as a vaccine vector for viral hemorrhagic fevers,http://vhfc.org/consortium/partners223,Lassa,Zalgen Labs,Zalgen Labs,America (AMRO),United States,"Germantown, MD","20271 Goldenrod Lane, Suite 2083",20876,301-515-5554,admin@zalgenlabs.com ,Public,www.zalgenlabs.com,Viral Hemorrhagic Fever Consortium,Therapeutics,Developing first-in-class immunotherapeutics against Lassa fever virus,http://vhfc.org/consortium/partners224,Lassa,National Institute of Allergies and Infectious Diseases (NIAID),National Institute of Allergies and Infectious Diseases (NIAID),America (AMRO),United States,"Bethesda, MD","5601 Fishers Lane, MSC 9806",20892-9806,866-284-4107,ocpostoffice@niaid.nih.gov,Public,https://www.niaid.nih.gov/Pages/default.aspx,Viral Hemorrhagic Fever Consortium,Funder,Awarded Tulane university a grant for Lassa Fever research,http://vhfc.org/consortium/partners225,Lassa,Redeemer’s University,Redeemer’s University,Africa (AFRO),Nigeria,Ede,Oshogbo Rd,N/A,234 700 700 8000,https://run.edu.ng/index.php,Academic,https://run.edu.ng/index.php,,Laboratory Methods,"Developed a test kit known as Pan-Lassa Rapid Diagnostics Test (PL RDT), that enables the testing of urine, faeces and blood samples of humans or multmamelar rats for Lassa fever in 10 minutes",http://www.vanguardngr.com/2016/02/redeemers-varsity-develops-10mins-lassa-fever-test-kit/226,Lassa,African Center for Excellence of Genomics of Infectious Disease,African Center for Excellence of Genomics of Infectious Disease,Africa (AFRO),Nigeria,"Redemption City, Ogun State","KM. 46, Lagos-Ibadan Expressway",N/A,N/A,info@acegid.org,Academic,http://acegid.org/,,Laboratory Methods,"Developed a test kit known as Pan-Lassa Rapid Diagnostics Test (PL RDT), that enables the testing of urine, faeces and blood samples of humans or multmamelar rats for Lassa fever in 10 minutes",http://www.vanguardngr.com/2016/02/redeemers-varsity-develops-10mins-lassa-fever-test-kit/227,Lassa,World Bank,World Bank,America (AMRO),United States,"Washington, DC",1818 H Street,20433,(202) 473-1000,N/A,Non - profit,www.worldbank.org,,Laboratory Methods,Funding work on Pan-Lassa Rapid Diagnostics Test,http://www.vanguardngr.com/2016/02/redeemers-varsity-develops-10mins-lassa-fever-test-kit/228,Lassa,Texas Biomedical Research Institute (Patterson Lab),Texas Biomedical Research Institute (Patterson Lab),America (AMRO),United States,"San Antonio, TX",P.O. Box 760549,78245-0549,(210) 258-9400,jpatters@txbiomed.org,Academic,https://www.txbiomed.org,,Vaccine,Worked with the University of Maryland on the development of two vaccines against Lassa fever,https://www.txbiomed.org/scientists/jean-patterson/229,Lassa,European Commission,European Commission,Europe (EURO),Europe,,Variety of local offices: http://ec.europa.eu/contact/local_offices_en.htm,,00800 67 89 10 11,http://europa.eu/contact/write-to-us/index_en.htm,Public,http://ec.europa.eu/index_en.htm,GloPID-R,Funder,Funding Unite de Biologie des Infectious Virales Emergentes for research on Lassa Fever ,https://research.pasteur.fr/fr/project/biology-of-viral-emerging-infections/230,Lassa,National Agency of Research,National Agency of Research,Europe (EURO),France,Paris,50 Daumesnil Avenue,75012 ,33 1 78 09 80 09,Nicolas.Ehrbar@agencerecherche.fr ,Public,http://www.agence-nationale-recherche.fr/,,Funder,Funding Unite de Biologie des Infectious Virales Emergentes for research on Lassa Fever ,https://research.pasteur.fr/fr/project/biology-of-viral-emerging-infections/231,Lassa,Fondation Recherche Medicale,Fondation Recherche Medicale,Europe (EURO),France,Paris,54 Rue de Varenne,75007,01 44 39 75 75,https://www.frm.org/contact,Non - profit,https://www.frm.org,,Funder,Funding Unite de Biologie des Infectious Virales Emergentes for research on Lassa Fever ,https://research.pasteur.fr/fr/project/biology-of-viral-emerging-infections/232,Lassa,Institut Pasteur,Institut Pasteur,Europe (EURO),France,Paris, 25-28 Rue du Dr Roux,75015,33 1 45 68 80 00,,Nonprofit ,http://www.pasteur.fr/en,,Funder,Funding Unite de Biologie des Infectious Virales Emergentes for research on Lassa Fever ,https://research.pasteur.fr/fr/project/biology-of-viral-emerging-infections/233,Lassa,Institut de microbiologie et des maladies infectieuses (INSERM),Institut de microbiologie et des maladies infectieuses (INSERM),Europe (EURO),France,N/A,N/A,N/A,N/A,http://www.inserm.fr/contact,Public/Private/Academic,http://english.inserm.fr/,,Funder,Funding Unite de Biologie des Infectious Virales Emergentes for research on Lassa Fever ,https://research.pasteur.fr/fr/project/biology-of-viral-emerging-infections/234,Lassa,Institut de Veille Sanitaire,Institut de Veille Sanitaire,Europe (EURO),France,Saint-Maurice,"12, rue du Val Osne",94415,01 41 79 67 00,http://www.santepubliquefrance.fr/Infos/Contacter-Sante-publique-France,Public,http://www.santepubliquefrance.fr,,Funder,Funding Unite de Biologie des Infectious Virales Emergentes for research on Lassa Fever ,https://research.pasteur.fr/fr/project/biology-of-viral-emerging-infections/235,Lassa,United States Army Medical Research Institute of Infectious Disease (USARMIID),United States Army Medical Research Institute of Infectious Disease (USARMIID),America (AMRO),United States,"Frederick, MD","Attn: MCMR-UIZ-R, 1425 Porter Street",21702-5011,(301) 619-2285,teresa.l.vanderlinden.civ@mail.mil,Public,http://www.usamriid.army.mil,ISARIC,Vaccine,Developing a replication-competent vaccine against Lassa virus based on attenuated recombinant vesicular stomatitis virus vectors expressing the Lassa viral glycoprotein,http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020183236,Lassa,Uniformed Services Universit of the Health Sciences,Uniformed Services Universit of the Health Sciences,America (AMRO),United States,"Bethesda, MD",4301 Jones Bridge Road,20814,(301) 295-3578,N/A,Academic,www.usuhs.edu,,Vaccine,Developing a replication-competent vaccine against Lassa virus based on attenuated recombinant vesicular stomatitis virus vectors expressing the Lassa viral glycoprotein,http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020183237,Lassa,Public Health Agency of Canada,Public Health Agency of Canada,America (AMRO),Canada,"Winnipeg, Manitoba",1015 Arlington Street,R3E 3R2,1-844-280-5020,http://www.phac-aspc.gc.ca/contac-eng.php,Public,http://www.phac-aspc.gc.ca/index-eng.php?utm_source=VanityURL&utm_medium=URL&utm_campaign=publichealth.gc.ca,,Vaccine,Developing a replication-competent vaccine against Lassa virus based on attenuated recombinant vesicular stomatitis virus vectors expressing the Lassa viral glycoprotein,http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020183238,Lassa,University of Manitoba,University of Manitoba,America (AMRO),Canada,"Winnipeg, Manitoba",N/A, R3T 2N2,1-800-432-1960,N/A,Academic,www.umanitoba.ca,,Vaccine,Developing a replication-competent vaccine against Lassa virus based on attenuated recombinant vesicular stomatitis virus vectors expressing the Lassa viral glycoprotein,http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020183239,Lassa,California State University,California State University,America (AMRO),United States,"San Marcos, CA",333 S. Twin Oaks Valley Rd,92096, 760-750-4000 ,N/A,Academic,http://www.csusm.edu/,,Vaccine,Developing a replication-competent vaccine against Lassa virus based on attenuated recombinant vesicular stomatitis virus vectors expressing the Lassa viral glycoprotein,http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020183